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ABSTRACT
The envelopment and egress of the Herpes Simplex Virus is an important event in the life
cycle of the virus. The important membrane proteins required for the envelopment and
egress of the virus are glycoproteins gM, gK, gE and non-glycosylated membrane
proteins UL20p and UL11. Among them one of the most critical protein is the UL20
protein which has four transmembrane domains with amino and carboxyl termini are
predicted to lie within the cytoplasmic side of cellular membranes. Studies done in our
laboratory have shown that deletion of UL20 or other lethal mutations have an adverse
effect on envelopment and results in accumulation of unenveloped capsids in the
cytoplasm of infected cells. The carboxyl termini of UL20 protein was shown to be
extremely important for viral egress. Mutant viruses were made with mutations in the
carboxyl termini of UL20p especially targeting phenylalanine residues as they are known
to be an important target for protein-protein interactions through stacking of the aromatic
structure. The two membrane proximal phenylalanines were very critical for efficient
replication as well as envelopment whereas, the middle phenylalanine at the carboxyl
terminus may have a negative effect with regard to the virus since the mutation helped
the virus to replicate, envelop and egress better.
Another glycoprotein shown to be playing a role in viral entry to susceptible cells or
neurons is Glycoprotein K (gK) especially the amino terminus of the protein. If the virus
has entered the cell but failed to enter nucleus and start protein synthesis, it is very
difficult to assess the entry of virus. In this scenario, the virus may be either stuck at the
cell membrane or the transport to the nucleus is adversely affected. In order to
demonstrate the entry of virus at a very early time point is quite challenging, but through
vi

Proximity Ligation assay (PLA) we have showed the importance of gK, the defect or less
efficiency of gK mutant virus in entry to epithelial cultured cells as well as in neurons at
a very early time point post infection.
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CHAPTER I
INTRODUCTION
Statement of Problem and Hypothesis
The

most

common

manifestation

of

HSV-1

infection

is

primary

herpetic

gingivostomatitis (PHGS) characterized by transient painful vesicles in and around mouth
which often affects the quality of life rather than a serious infection. Ocular herpes viral
infection is considered as the leading cause of infectious blindness in developed
countries. The herpes virus is capable of establishing latency in the trigeminal ganglia. So
once infection occurs, then they are incurable and persist throughout the lifetime of the
host. Apart from recurrence that occur spontaneously, there are a many extrinsic and
intrinsic factors that can cause viral reactivation like stress, exposure to sunlight,
menstrual cycle, immunosupression, treatment with corticosteroids, and trauma. The
double-stranded viral DNA genome is enclosed within an icosahedral nucleocapsids,
surrounded by proteinaceous tegument layer and lipid envelop embedded with
glycoproteins.
Envelop proteins play an important role in the life-cycle events of HSV-1 like
envelopment/egress and entry. It is believed that the virus acquire a primary envelope
when mature capsid bud from nucleus to perinuclear space. De-envelopment results from
the fusion between outer nuclear membrane and viral envelopes and the capsids released
to the cytoplasm of infected cells undergo secondary envelopment in cytoplasmic
vesicles derived from trans-golgi network (TGN) or endosomes and final egress happen
to extracellular space [1]. Till date nobody has proved the exact mechanism and viral
proteins involved in envelopment and egress.
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Studies conducted in our laboratory have shown that UL20 protein serves crucial roles in
cytoplasmic virion envelopment in comparison to other viral glycoprotein [2]. Deletion of
just either 6 (UL20∆216t) or 11 amino acids (UL20∆211t) allowed efficient UL20p
intracellular transport and cell surface expression, but failed to complement for infectious
virus production affecting the envelopment and egress. Phenylalanine residues are
aromatic and hydrophobic amino acids that have been shown to play an important role in
respiratory syncytial virus assembly [3]. We hypothezis that phenylalanine at the
carboxyl terminus of UL20p are important for virion envelopment and egress.
Another important Glycoprotein in the virion envelop is gK which plays multiple roles in
viral entry, virion fusion, egress and envelopment [2, 4-6]. It has been shown that gK is
important for viral corneal spread and neuroinvasiveness [7] as well as for both
retrograde and anterograde spread along axons of neurons [8]. Deletion of amino
terminus of gK (gK31-68) slowed the entry of virus into epithelial cells [6]. PLA has
been a novel technique to explore protein interactions using DNA along with processes
like ligation, cleavage, and polymerization [9]. We also hypothesize that through PLA
experiments showing association between inner tegument protein UL37 and motor
protein dynein can be utilized to show the delay in the entry of gK amino terminus
mutant to epithelial and neuronal cells.
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Statement of Research Objectives
The main aims of this research was to investigate the importance of carboxyl terminal of
UL20p in HSV-1 with regard to virion envelopment and egress with special emphasis on
aromatic amino acid phenylalanine and also to investigate the role of gK with regard to
entry in both epithelial and neuronal cell culture.
The research objectives were:
I.

To investigate the role of carboxyl terminus amino acids of UL20p especially
phenylalanine residues in virion replication and spread:
1. To generate and validate a set of mutant viruses having deletion of
phenylalanine residues at the carboxyl terminus or replacement of them
with alanine residues in HSV-1 (F) VC-1 genome cloned on bacterial
artificial chromosome (BAC) using two-step red double recombination
method.
2. To characterize the phenotypes of mutant viruses using plaque
morphology, fusogenic capacity using luciferase assay, expression
profiling using immunoprecipitation/western blotting and virus replication
curves.

II.

To investigate the role of phenylalanine residues at the carboxyl terminus of
UL20p of HSV-1 with regard to viral envelopment and egress:
1. To analyze the ability of mutants to envelop and egress using q-PCR, and
to study the transport of UL20p to TGN, an important step during
envelopment, using confocal microscopy through colocalization.
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2. To compare the interaction of UL20p with an important tegument
proteinUL37 during envelopment of mutant viruses with wild-type virus
using proximity ligation assay (PLA).
3. To investigate the ultra structural phenotype of viruses with phenylalanine
mutations on carboxyl-terminus of UL20p exhibiting defects in virion
egress and spread.
III.

To investigate the role of amino terminus HSV-1 gK with regard to entry in
both epithelial and neuronal cell culture.
1. To standardize and utilize the PLA technique in studying the entry of
HSV-1 virus to cells.
2. To compare the defects of gk mutant viruses for entry in both epithelial
cells and neuronal cells by acquiring signals of PLA in confocal
microscope.
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CHAPTER II
REVIEW OF LITERATURE
History of Herpesviruses
The occurrence of human herpes simplex virus infections was documented in the ancient
Greek times. The Greek scholar Hippocrates described the lesions using the word
“herpes” which means to creep or crawl along the skin [10]. The link between cutaneous
lesions caused by HSV and the related fever was pointed out by Herodotus and
recurrence of the lesion at same anatomic site was recognized by Galen [11]. In 1736
John Astruc, a physician for King Louis XIV of France published De Morbis Veneris
after he found a connection between HSV and the genital organs after studying the
disease in French prostitutes [12]. Later in the early 19th century Thomas Bateman
described herpes as “a restricted group of localized vesicles with a short, self-limiting
course” (Bateman, 1814). In 1873, Vidal demonstrated that the disease was infectious
and can cause reinfection in a new anatomical site by re-inoculating the herpetic lesion
materials.
During early 20th century, Cushing from his observations came up with the concept of
latency by suggesting that posterior root ganglia were responsible for the occurrence of
herpes [13]. Gruter is credited for using an animal model for showing the infectious
nature of virus by studying the spread of HSV among rabbits and he is acknowledged for
the isolation of the virus [14]. As a therapeutic measure herpetic vesicular fluid was
inoculated into forearm skin in both animals well as in humans [15]16].
Later new technologies like tissue culture accelerated the isolation and identification of
other viruses in the herpes family. In 1950’s, Vericella Zoster Virus (VZV), causative
5

agent of chicken pox, and cytomegalovirus (CMV) [17], immune system associated
herpes viruses like human herpesvirus 4 (HHV-4; Epstein-Barr virus) [18] and human
herpesviruses 6A, 6B, and 7 [19, 20] were isolated as a result of cultivation of
lymphoblastoid tumor cells, B cells and T cells respectively. Newly, human herpesvirus
8 was isolated through Representational Differential Analysis (RDA) [21]
Taxonomy of Herpesviruses
Herpesviruses are complex viruses due to their large genomic size and a complicated
lifecycle. The human Herpesviridae family consists of eight members: HSV-1 and 2 as
well as varicella-zoster virus (VZV) under subfamily Alphaherpesviruses, human
cytomegalovirus (HCMV) and roseoloviruses (HHV-6 and -7) under Betaherpesviruses
and

Epstein-Barr

virus

(EBV),

Kaposi-sarcoma

herpesvirus

(KSHV)

under

Gammaherpesviruses. Table 1.1 summarizes all the nine known human herpesviruses
along with commonly studied herpesviruses [22, 23].
Alphaherpesvirinae subfamily was classified on factors like diverse host range, short
reproductive cycle, fast spread in tissue culture, efficient lysis of susceptible cells and
establishment of latency mainly in sensory ganglia. Genera’s included under the
subfamily include Simplexvirus, Varicellovirus, Marek’s disease-like virus, and
Infectious laryngotracheitis-like virus [23].
Betaherpesvirinae subfamily was classified on factors like small host range, long
reproductive cycle, and slow progression of infection on tissue culture. Infected cells are
characterized by enlargement called cytomegaly, and viruses are capable of going latent
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Table 1.1: Members of the family Herpesviridae

Subfamily
Alphaherpesvirinae

Designation
Human herpesvirus 1 (HHV-1)
Human herpesvirus 2 (HHV-2)
Human herpesvirus 3 (HHV-3)
Gallid herpesvirus 1 (GaHV-1)
Gallid herpesvirus 2 (GaHV-2)
Suid herpesvirus 1 (SuHV-1)
Felid herpesvirus 1 (FeHV-1)

Betaherpesvirinae

Gammaherpesvirinae

Ictalurid herpesvirus 1 (IcHV-1)
Bovine herpesvirus 1 (BoHV-1)
Equid herpesvirus 1 (EHV-1)
Human herpesvirus 5 (HHV-5)
Human herpesvirus 6A (HHV-6A)
Human herpesvirus 6B (HHV-6B)
Human herpesvirus 7 (HHV-7)
Human herpesvirus 4 (HHV-4)
Human herpesvirus 8 (HHV-8)
Canid herpesvirus 1 (CaHV-1)
Ovine herpesvirus 2

Vernacular Name
Herpes simplex virus type 1 (HSV-1)
Herpes simplex virus type 2 (HSV-2)
Varicella-zoster virus (VZV), shingles,
chicken pox.
Infectious laryngotracheitis virus
Marek’s disease virus
Pseudorabies virus, Aujesky’sdisease virus
Feline herpesvirus 1, Feline rhinotracheitis
virus
Channel catfish herpesvirus
Infectious bovine rhinotracheitis virus
Equine HV-1, Equine abortion virus
Cytomegalovirus (CMV)
Roselovirus

Epstein-Barr virus (EBV)
Kaposi's sarcoma-associated herpesvirus
(KSHV)
Canine herpesvirus
Sheep-associated malignant catarrhal fever

in secretory glands, kidneys and other tissues. Genera’s included in the subfamily are
Cytomegalovirus, Muromegalovirus, and Roseolovirus [23].
Gammaherpesvirinae subfamily was classified on factors like limited host range and
ability to replicate in lymphoblastoid cells. Latency has been frequently shown in
lymphoid tissues and viruses are specifically for B cells or T cells. The genera’s included
are Lymphocryptovirus (EBV), and Rhadinovirus [23].
Structure of Virus
HSV-1 genome consists of double-stranded DNA enclosed within an icosahedral
nucleocapsid, which is surrounded by a lipid envelop embedded with glycoproteins.
7

Between nucleocapsids and envelope lies a proteinaceous layer called tegument (Fig 1.1).
The nucleocapsid houses DNA, in a densely coiled liquid crystalline arrangement [24]
and it is one of the similarities HSV-1 shares with bacteriophages [25]. There are three
types of capsids isolated from the viral infection, A, B, C capsids. They are icosahedral in
shape and were made of 162 capsomers, but the difference was in their core content.
Only capsid C contains viral DNA and are able to mature to infectious virus [26, 27]. An
additional structure found in the C capsids or the capsids in the complete virion is the C
capsid specific component (CCSC) and is absent in the A or B capsids of virus.[28].
Works done both in vivo and in vitro has shed light on the pathway for HSV-1 capsid
assembly [26, 29, 30]. Capsid shell is made of proteins UL19, UL35, UL18, UL38 and the
scaffolding protein UL26.5 which is lost during maturation of procapsid to mature capsid.
Portal system is a ring shaped structure made of which viral DNA enters and exit from
the capsid [31, 32]. The viral envelop is made up of 11 glycoproteins and the tegument is
made of 20 virally encoded proteins.
Mostly viruses are observed as round shape although they could be in different shapes.
The lipid bilayer is around ∼5 nm thick and the diameter ranged between 170 to 200 nm.
The diameter taking into account membrane proteins decorating the envelope averages
∼225 nm. Nucleocapsid occupied an eccentric position inside the envelope and linkers or
∼4 nm connected tegument cap with the envelope. There number of protein spikes on the
envelope varies from 600 to 750. The spikes are 10 to 25 nm long, ∼4 nm wide and
ended in a globular structure ∼6 nm across. There are variation in the angles of
protrusion and straightness of spikes [25]
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two inverted pentanucleotide repeats, boxes I and II of the HSV-1 origin of replication,
OriS. UL9 protein also possesses DNA-dependent ATPase and 3′-5′ helicase activities
[35] The six important proteins for replication are: a single-strand DNA-binding protein
(known as ICP8 or UL29), a two-subunit DNA polymerase (catalytic subunit Pol and
processivity subunit UL42), and a three-subunit helicase/primase complex (H/P:UL5,
UL8, and UL52)[36]. H/P complex is recruited once ICP8 and UL9 have unwounded the
DNA at the site of replication. Subsequently polymerase complex is recruited for DNA
synthesis leading to the formation of tandem head to tail concatemeric DNA which
accumulate in the nuclei which are later cleaved at regular intervals to monomeric units
and finally encapsidation to generate progeny virus. There is a higher rate for
recombination among herpes viruses [37].
Clinical Manifestation
HSV-1 is more important causative agent than HSV-2 in causing ocular disease,
characterized by conjunctivitis, iridocyclitis, acute retinal necrosis and keratitis. HSV-2 is
the main culprit behind various genital infections and is a sexually transmitted disease
[38, 39].We could notice an endemic pattern of distribution for herpes virus infection in
the natural human host of the virus throughout the world irrespective of level of
civilization that is from highly developed urban population to native tribal population
[40]. Predilection sites for latency occurs in trigeminal ganglia for HSV-1 and sacral
ganglia for HSV-2 as they cause infections in the face and genital areas respectively.
Recurrent infection of herpes virus is not considered as reinfection by virus, but it is due
to viral reactivation from latency [41]. Apart from recurrence that occur spontaneously,
there are many extrinsic and intrinsic factors that can cause viral reactivation like stress,
10

exposure

to

sunlight,

menstrual

cycle,

immunosuppression,

treatment

with

corticosteroids, tissue damage and trauma [42]. Viral reactivation not always leads to
clinical manifestation of disease, but can cause asymptomatic shedding of virus known as
recurrence [39, 43] and viral reactivation with clinical signs of disease are known as
recrudescence. Transmission of HSV-1 occurs mainly through oral secretions and lesions
are mainly associated with eyes, face, pharynx, and central nervous system infections.
The ability of virus to remain viable on fomites and skin helps in horizontal transmission
through social contacts like kissing and shaking hands [44, 45]. There are two kinds of
initial herpes virus infections; a) True primary infection and b) nonprimary infection.
True primary infection occurs when a HSV-1 seronegative individual gets infected with
the virus and the infection usually more severe and having a prolonged duration of viral
shedding [38, 46, 47]. Nonprimary infection occurs when a new strain of HSV-1 infects
an already infected person with another strain of HSV-1 [38, 48]. Primary infection is
characterized by elevated levels of IgM, while in the case of nonprimary infection there is
an elevated level of IgG. The most common manifestation of HSV-1 infection is primary
herpetic gingivostomatitis (PHGS) characterized by transient vesicles in and around
mouth [49]. Spread of virus to new hosts or different regions of the body is facilitated by
rupture of the vesicles. The most common form of recurrent herpes infection is Herpes
simplex labialis characterized by the presence of painful vesicles on the outer vermilion
border and adjacent cutaneous region [50] which heal in a span of 2 weeks, but
dissemination of virus continues for 3 to 5 days after healing [51].
Herpes infection is considered as the leading cause of infectious blindness in the
developed countries [52]. Ocular manifestation can be the result of primary infections or
11

recurrent infections. HSV epithelial keratitis initiates as a superficial punctate lesion,
developing to a stellate erosion and ultimately leading to dendritic ulcer [53, 54].
Although immune system is capable of clearing the infection, virus can travel retrograde
axonal transport through sensory neurons before establishing latency in the trigeminal
ganglia. So once infection occurs, then they are incurable and persist in latent infection
throughout the lifetime of the host. Primary evidence for the transport of virus to central
nervous system came to notice as the virus causes herpes encephalitis [55]. Areas of
brain damaged by the virus are the anterior perforated substance, amygdala, insula,
hippocampus, mammillary bodies and cingulate gyrus [56-58]. There are two schools of
thoughts regarding entry of the virus to brain. A) Entry may be through trigeminal nerve
and reach meninges covering the temporal lobe [59], from there infecting limbic system
structures. B) Entry to brain through the olfactory system [60]. HSV-1 and -2 and VZV
can cause facial, genital ulcers and in rare cases encephalitis. CMV infection is of
concern in immunocompromised people and HHV-6 as well as HHV-7 cause exanthum
subitum or roseola infantum in infants. Whereas, EBV causes infectious mononucleosis
and can exist in latency in individual’s B cells and KSHV causes Kaposi's sarcoma.
HSV-1 and HSV-2 share similarities in their genomic sequence, but since their envelope
proteins differ they are considered antigenically distinct [38, 44].
Epidemiology
Studies have shown that seroprevalence of HSV-1 is greater than 50%, 75% and 90% in
the general adult populations of the countries the United States, Germany, and Tanzania
respectively [61, 62]. Thus most of the people are infected with HSV-1 and carry a latent
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infection in them. In the United States, around 500,000 people have ocular HSV and the
country has to spend 17.7 million US$ annually for the treatment of the disease [63, 64].
Additionally, incidence of HSV-1 infection is greatly influenced by race as well as socioeconomic condition. By the age of 5 years, 35% of black kids are seropositive for HSV-1
antibodies in comparison to 18% of white kids [65]. Whereas, 33% of kids in lower
socioeconomic background are seropositive for the infection by the age of 5 years and
percentages reach up to 70 -80 % by late puberty [65, 66]. In contrast, only 20% of kids
in higher socioeconomic background are seropositive for HSV-1 by age 5 and 40% to
60% by late adolescence [42, 65].
The world wide prevalence of HSV-1 comes to be around 90%, whereas prevalence in
United State of America is 65% [67] and in northern Europe 52-67% [68]. The generally
accepted facts are 1) Latency is due to failure to start the expression of immediate early
genes (IE); 2) Latent DNA is maintained in a non-linear configuration as a circular
episome; 3) The latency-associated transcripts (LATs) are the only viral gene products
produced in latently infected cells; 4) Finally reactivation causes activation of virus gene
expression and entry into lytic phase [69].
The molecular basis of Herpes Simplex Virus latency
All herpesviruses have the unique characteristic ability to establish life-long latency in
the infected host. The latency can be periodically interrupted leading to reactivation and
dissemination of infection to newer host upon instances like immunosuppression. This is
a highly efficient survival system they have evolved to maintain as well as to perpetuate
infection. After primary replication in the oral mucosa, HSV-1 virus enters the sensory
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neuronal termini innervating the site of infection and is carried in a retrograde direction to
establish latency in the trigeminal ganglia.
An important event for lytic cascade is the association of VP16 viral protein with
two cellular factors, Octamer binding protein-1 (Oct-1) and host cell factor (HCF) and
binding to TAATGARAT region in the promoter sequence for the five IE genes ICP4,
ICP0, ICP22, ICP27, and ICP47 [70]. The basic requisite for latency is failure of IE gene
activation. This could be due to inadequate quantity of VP16 reaching the neuronal
nucleus after the virus traverses long distance through the axon [71]. HSV latency
associated promoter has been associated with acetylated histone H3, whereas decreased
association have been seen for IE as well as early gene promoters through chromatin
immunoprecipitation studies [72, 73]. Only expressed viral gene product during latency
are LATs, which are polyadenylated non-coding RNA. They are transcribed from repeat
regions flanking the unique long regions of herpes viral genome[74]. The size of primary
transcript is 8.3kb and which then subsequently spliced to 2.0 kb intron and finally into
1.5 kb intron [75]. Studies have shown that the of 3′ end of the first exon and 5′ end of the
stable 2.0 kb LAT intron protects the cells from going into apoptosis [76].
Herpes virus encoded miRNAs play important roles in latent/lytic cycle control, evasion
of immune system, and cellular survivability [77]. HSV-1 encodes 16 siRNAs and of
which six miRNAs (miR-H2, H3, H4, H5, H7 and H8) are encoded within the 8.3 kb
primary LAT [78]. Co-transfection studies have shown that miR-H2 and miR-H6
decreased the amount of proteins ICP0 and ICP4, showing the part played by miRNA in
suppressing the lytic phase and supporting the latent state of infection. The virus has
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shown to encode several proteins gD and gJ, as well as protein kinase Us3, ICP27 and
ICP10 to prevent apoptosis of cells [33, 79-81].
As mentioned before, the key factor for a cell to enter lytic cycle is counting on
the transactivating function of the viral protein VP16 and formation of a complex with
HCF-1 and Oct-1 [70]. There has been a school of thought that in case of neurons VP16
may be inefficiently transported through the axons leading to an insufficient
accumulation in the neuronal cell body [71]. The unique cytoplasmic localization of
HCF-1 [82] and down regulation of Oct-1 [83] in neuronal cells were roadblocks in the
formation of VP16-induced complex leading to suboptimal activation of IE promoters
and subsequent latency stage. However, till now no study is able to find the reason
behind why the virus cannot go latent in vitro. Most of the latency studies have been
done in mice, but reactivation does not cause reinfection at the site of infection like in
humans. Most common stimuli used for in vivo reactivation are the use of adrenergic
agents like epinephrine.
Immune Response against HSV-1
Viral replication in the peripheral epithelial cells activates the innate immune response
through type 1 interferons (IFNs) released by macrophages and the interferons help to
protect neighboring susceptible cells from infection. Neutrophils invading the site of
infection cause apoptosis of infected cells and also phagocytes them. Macrophages in the
primary site of infection and in the trigeminal ganglia play a vital role in controlling viral
replication [84, 85]. Table1.2 has summarized the HSV-1 pathogen recognition receptors
(PRRs) and the corresponding pathogen associated molecular patters (PAMPs).
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Dendritic cells (DCs) take up the viral proteins and process them to present to
lymphocytes to activate adaptive immune system [86]. Activated T lymphocytes, Thelper (CD4+) and cytotoxic T cells (CD8+) take part in clearing infection. Whereas, Bcells play the role of presenting antigens and secreting cytokines rather than producing
neutralizing antibodies [87]. The unmethylated CpG motifs on HSV-1 genome is detected
by Toll-like receptor 9 (TLR-9) in the membrane of endosomal compartments. Whereas,
PRR TLR-9 on plasmacytoid DCs and B cells can detect endocytosed DNA of HSV-1
[88, 89]. Recognizing herpes virus by TLR2 causes an influx of inflammatory cytokines
in the brain leading to encephalitis [90]. Pathogen recognition receptor (PRR) TLR-3 can
recognize dsRNA in the endosomes which are intermediate in herpes viral replication
[91]. Studies have shown that susceptibility for herpes encephalitis is more in children
who are genetically deficient in TLR-3 receptor [92-94]. Most of the TLRs signal through
adaptor myeloid differentiation primary response gene 88 (MyD88) for producing
downstream type I IFNs [95, 96]. Innate immune response is critical for controlling viral
replication at the site of infection. Studies have shown that in IFN A1 receptor knockout
mice where type I IFN signaling is absent results in higher host morbidity and mortality
[97, 98]. Cytosolic short dsRNA and longer dsRNA of herpes virus are detected by
retinoic acid inducible gene (RIG)-like receptors (RLRs) and melanoma differentiationassociated gene 5 (MDA-5) [99, 100]. All Toll-like receptors and nucleic acid sensors
activate intracellular signaling cascade that leads to the induction of pro-inflammatory
cytokines such as IL-8, RANTES and IL-1β [101] and type I IFNs (IFNα and IFNβ)
promoting antimicrobicidal functions and inflammations. [102]. Table showing PRRs and
HSV-1 are shown in table 1.2.[103]. IFNα and IFNβ are responsible for the activation of
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the Jak/STAT pathway which leads to the expression of ISGs (Interferon Stimulated
Genes) that encode antiviral factors. Inflammasomes are activated by herpes viruses
leading to the activity of caspase-1. AIM2 (An interferon-inducible protein, absent in
melanoma 2) act as sensor of viral genomes in the cytoplasm leading to caspase-1
activation [104] and interacts with apoptosis-associated speck-like protein containing a
CARD (Capsase Recruitment Domain) recruiting pro-caspase-1, followed by production
of active caspase-1 and mature IL-1β and IL-18.
Life cycle of HSV-1
HSV-1 enter cells by membrane fusion between viral and cell membrane. Viral proteins
gB or gC interact with heparan sulfate proteoglycans (HSPGs) present on the filopodia of
cells [105]. It has been shown that cells lacking HSPGs, can get infected through another
receptor called paired immunoglobulin like type 2 receptor alpha (PILRα) through gB
envelop protein [106]. When PILRα is expressed on Chinese hamster ovary (CHO) cells,
viral entry happens through fusion at the plasma membrane. On the other hand, entry
happened through endocytosis when CHO cells are expressing nectin1 or herpesvirus
entry mediator (HVEM) [107, 108]. In human cells, changes happen in the cytoskeleton
for facilitating viral entry through cdc42 (Cell Division Control Protein 42)[109], FAK-1
(Focal Adhesion Kinase) [110] and phosphoinositide 3 kinase [111].
Glycoprotein D of herpes virus interacts with three different families of cellular receptors
and this interaction determines the tropism of the virus as well as the fusion mechanism.
HVEM helps in entry apart from its role in apoptosis through the tumor necrosis factor
(TNFR) [112]. Other receptors include nectin-1 and nectin-2, which are the members of
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Table 1.2: Herpes Simplex Type-1 associated pathogen associated molecular patterns
(PAMPS) and the corresponding pathogen recognizing receptors (PRRS)

Pathogen Recognizing Receptors (PRRs)
TLR2

Pathogen (HSV-1) associated molecular patterns
(PAMPs)
Viral component and dsRNA

TLR7

Genomic DNA

TLR9

Endocytosed DNA

MDA5

Replication intermediate and Genomic DNA
Genomic DNA

Pol III / RIG-I
IFI16

Genomic DNA

immunoglobulin (Ig) family, and 3-O sulfated heparan sulfate (3-OS-HS), a
polysaccharide belonging to the Heparan Sulphate family [113]. Nectins are
transmembrane proteins abundantly found on nervous system [114] and interacts through
afadin with actin, thus functions in intercellular adhesion system found in synaptic as
well as adherens junctions [115]. Receptors used by virus depend on the type of the
uninfected susceptible cells. For example, entering epithelial cells nectin-1 is preferred by
the virus [116], while for T lymphocytes HVEM is the major receptor. Interaction with
receptors acts like a catalyst [117] triggering conformational changes and ultimately
causing fusion with the help of envelop proteins gB and gH/gL. During fusion
“hemifusion intermediate” is formed by the mixing of lipids as well as the membranes
of the cell and virus, ultimately forming a fusion pore allowing mixing of cytoplasmic
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content of cell with viral contents leading to the entry of nucleocapsids with tegument
proteins into the cytoplasm of the cell [118].

Of all proteins involved, gB is the

membrane fusogen and most conserved among viral membrane proteins involved in entry
[119]. Interactions have been demonstrated between gD:gH/gL, gD:gB, gH/gL:gB [120122]. Multinucleated cells or syncytia are produced when all the four glycoproteins were
expressed together in COS cells and syncytial formation failed when only one or two
proteins were expressed [123, 124]. Another major pathway for HSV entry into HeLa and
CHO-K1 cell lines is by endocytosis and this can be prevented by reagents that increase
endosomal pH, indicating the importance of passage through acidic compartments [125].
After endocytosis of enveloped viruses, fusion between viral and cellular membranes
leads to release of the nucleocapsid into the cytoplasm. Whatever be the route of entry,
tegument protein VP16 promotes transcription of immediate early or α viral genes
leading to a cascade of activation leading to transcription of early or β genes and finally
those β genes products helps in viral DNA replication as well as activate the late or γ
genes which encode viral structural proteins [126]. ICP0, 4, 22 and 27 are the α viral
proteins responsible for the transcription herpes genome. In some cases ICP4 has been
shown to have a negative effect on transcription of genes [127]. ICP22 functions along
with virus associated protein kinase UL13 by influencing phosphorylation and affecting
RNA polymerase II functions [128]. ICP27 may also associate with RNA polymerase II
and influence its functions [129]. Virion host shut-off (Vhs) is a tegument protein, which
has RNase or RNAase component in association with the translation initiation factor
eIF4H, which chew off the cellular mRNAs and thus favor expression of viral transcripts
[130]. DNA viruses including herpes viruses replicates in the subnuclear structures called
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transcription/replication by making use of its components or to prevent its negative effect
on viral lifecycle. ICP0 is acts as a promiscuous transactivator and it separates HDACs 1
and 2 from the CoREST/REST repressor complex, thus prevents viral DNA silencing
[132]. There is circularization of linear genome of herpes virus within 30 minutes of
entry to cells [133] . Spread of infection to susceptible neighboring cells happens through
virus released to infected cells or through direct cell-to cell spread [134]. During egress
the virus nucleocapsid first acquires tegument proteins and then envelope. The most
supported school of thought is the envelopment-de-envelopment theory put forward by
Stackpole [135]. The herpes virion morphogenesis and egress occurs through a complex
mechanism characterized by: a) primary envelopment of capsids at the inner nuclear
membrane; b) de-envelopment of them at the outer nuclear membrane; c) cytoplasmic
capsids acquire sets of tegument proteins; d) re-envelopment of tegumented capsids into
TGN-derived membranes [1].
Transport and Egress of HSV-1
If the transport is only through diffusion, HSV-1 capsid could take around 230 years to
move just 1 cm through cytoplasm [136]. However in the case of in vitro infection of
cultured cells, capsids may move by diffusion to reach nucleus since at the apical surface
it lies very close to cytoplasm [137]. On the other hand virus will be adopting more
sophisticated transport mechanism for traveling through long sensory neurons during its
life cycle. For the transport of cargos like organelles or vesicles, cells make use of
microtubules and motor proteins like kinesin or dynein.
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Microtubules are made of alphabeta-tubulin heterodimers. Dynein motors move cargos
from minus end of microtubule towards the nucleus to microtubule organizing center
(MTOC), whereas kinesin motors transport cargos towards periphery that is to the plusends of the microtubules [138]. Viruses encode only limited number of proteins required
to complete its life cycle since their genomes are small. So they make use of cellular
mechanisms for their own benefit. The size of dynein is Mr 1.2 x 106 and is made of
heavy chains, intermediate chains, light intermediate chains and light chains. The
different combinations of the light and intermediate chains decide the specificity of cargo
binding [139]. Dynactin is a co-factor of dynein which regulates its functions [140]. The
retrograde transport of capsids requires microtubular network and the transport is
disrupted by microtubular inhibitors like colchicine, vinblastine, or nocodazole [141].
Speed for retrograde transport is roughly 200±300 mm/day in animals and 3±5 mm/h in
culture [142, 143].

The viral protein first shown to bind with dynein was pUL34 [144] and the capsid protein
VP26 (pUL35) is important for retrograde transport of virus [145]. Proteins predicted to
interact with dynein are in the inner tegument or outer capsid. For example capsid protein
pUL35 (VP26) has been shown to interact with dynein through colocalization by
microinjecting recombinant capsids into live cells and transport of capsids towards
nucleus [145]. Dystonin is a cytoskeletal linker protein present at the plus end and
function in both retrograde as well as anterograde transport in neurons. Travel to the
centrosome by capsid is through minus-ended transport while further towards nucleus is
by plus-ended transport. Depletion of dystonin did not affect the transport of capsid to the
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centrosome, but had a deleterious effect on further transport towards nucleus [146].
Same group have also shown that dystonin interacts with herpes tegument protein pUL37
and is indispensable for efficient egress of capsids [147]. Membrane glycoprotein gK is
required throughout the life cycle of the virus from entry to egress [148]. An in vitro
transport study in neurons using microfluidic device showed that gK is essential for
infection of neuronal axons, may be due to lack of regulatory role of gK on gB during
entry process caused by the fusion between viral membrane with axonal synaptic
membrane [8]. Anterograde transport refers to transport from the neuronal cell body to
axons and there are models proposed for herpes virus anterograde transport through
neurons. In cultured sensory neurons newly formed capsids are moving in both directions
with a net movement towards the plus-end direction [149]. In separate model, naked
nucleocapsids devoid of any membrane proteins are transported down the axons, whereas
in the married model complete virions together with the membrane proteins are
transported [150]. Brefeldin-A (BFA) is a chemical which can cause disruption of Golgi
apparatus and thus affect egress by interfering assembly of virions [151]. A study has
shown that BFA caused inhibition in the anterograde transport of glycoproteins and had
no effect in the transport of nucleocapsids supporting the separate model [152]. Whereas,
transmission electron microscopic images of the proximal and mid-axons of primary
superior cervical ganglion (SCG) neurons showed that complete virions were present in
case of HSV-1 NS and 17, HSV-2 2.12 and PRV Becker infections supporting the
married model for transport [153]. On the contrary, another group has supported the
separate model of anterograde transport by showing in HSV infected murine retinal
ganglion cell model that US9 is necessary for the efficient anterograde transport
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specifically of viral capsid and DNA, but not required for the viral envelope
glycoproteins anterograde transport [154]. UL36 (VP1/2) encodes the largest HSV1
tegument protein having a molecular weight of 273 kDa and has been shown to be
important for binding to microtubule and also transport down the axon [155]. Motors that
function in transporting cargoes from inside to plus end of microtubules located at the
periphery of cells are kinesins [156] and make use of energy from ATP for
conformational changes to generate motile force [157]. Kinesin protein superfamily
consist of 15 members named kinesin 1 to kinesin 14 B. First kinesin discovered is the
tetrameric Kinesin 1 [158], made of two identical light chains of Mr 64000 and two
identical heavy chains of Mr 120000 [159]. Based on the location of the motor domain
they are classified into three types; N-kinesins, M-kinesins and C-kinesins if motor
domain is in the amino-terminal, middle or carboxyl-terminal region of the protein
respectively. N-kinesins and C-kinesins are involved in the microtubule plus and minus
end transport, whereas M-kinesins depolymerize microtubules. For anterograde transport
cell make use of N-kinesins and for retrograde transport other than dynein, C-kinesins
can also help [156]. In polarized non-neuronal cells, enveloped complete viruses are
transported from the Golgi network to cell surface [160, 161]. Interaction has been
demonstrated between viral proteins and proteins of cell important for secretory and
exocytosis pathways in neurons like TGN-46 (marker protein of trans-Golgi network),
Kinesin-1, GAP-43 (neuron-specific protein), Rab3A (regulatory protein in intracellular
trafficking), and SNAP-25 (Q-SNARE protein) [162].
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gK/UL20 Role in Envelopment and Egress
HSV-1 nucleocapsid in the cytoplasm acquires envelop by budding into trans-Golgi
network (TGN)-derived membranes. The two important membrane associated proteins at
the TGN are picked up by the virus at the TGN. Mature viruses depend on cellular
secretory pathway to be transported to cell surface to egress [1]. Genes shown to be
important for secondary envelopment are PrV gB [163], HSV-1 gK, UL20p, gE, gM, gD,
UL11, UL48 [164-169], and PRV US3 [170]. gK/UL20 proteins were found to be the
most vital components for cytoplasmic virion envelopment, egress and infectious virus
production when compared to gM, gD, UL11, and gE [2]. gK and UL20p have multiple
membrane spanning domains and are highly conserved among the members of
alphaherpesviruses [171]. gK is made of 338 amino acids and UL20p is made of 222
amino acids. Interactions between membrane and tegument proteins are required for
proper envelopment and egress and this may be affected in gK/UL20 mutant virus
causing problems in secondary envelopment. Studies have also shown that UL20p in
PRV functions in cell-cell spread and egress form infected cells. Electron micrographs
showed that in UL20p mutant PrV virus, there was accumulation of enveloped viral
particles in the cytoplasmic vesicles of Vero cells. This observation is different in HSV-1
since deletion of UL20p caused accumulation in the perinuclear space of infected Vero
cells [172]. These observations point out the fact the UL20p function definitely in egress
but may be at different step during the process. Similarly HSV-1 gK was also shown to
be important for regulation of egress of new virion particle from cells since the HSV-1
mutant F-gKβ lacking gK protein causes accumulation of enveloped and unenveloped
virus particles in the cytoplasm of cells [173]. Apart from cellular viral envelopment and
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egress, the two proteins of HSV-1 gK and UL20p are important for virus-induced cell
fusion and mutations in either genes can cause extensive fusion between cells forming
syncytia [174-176]. There were different experimental results suggesting the
interdependence of gK and UL20p to function together indicating a physical and
functional interaction between them. Confocal colocalization experiments showed that
both proteins are essential for transport within cells, cell surface expression, cell induced
fusion and cytoplasmic envelopment and egress [177-179]. The predicted structures of
the proteins are mirror images of each other with amino and carboxyl termini of gK
facing extracellular region while that of UL20p facing intracellular. Immunoprecipitation
and western blot have demonstrated the physical interaction between gK and UL20p and
most specifically between cytoplasmic domain III of gK and amino-terminal of UL20p
[180]. The role of gK /UL20p in nuclear egress is not suspected as retention of UL20p
resulted in accumulation of nucleocapsids in the cytoplasm of cells [174].
Membrane Proteins of HSV-1
UL20 Protein/ Glycoprotein K (UL20/gk)
UL20p is a structural protein made of 222 amino-acids which is non-glycosylated and has
transmembrane domains. In infected cells distribution of the protein is mainly perinuclear
and cytoplasmic [181]. Glycoprotein K (gK) like UL20p has multiple transmembrane
regions and is made of 338 amino acids encoded by the UL53 open reading frame. The
protein has two potential sites for N glycosylation and has a 30-amino acid long cleavable
signal sequence at the amino terminal [182]. Among alpha herpesviruses like HSV-1,
PrV, and varicella-zoster virus, gK mutant virus showed a defect in virion envelopment
and egress.
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Both gK as well as UL20p is highly conserved among all alphaherpesviruses [183, 184].
The structures of gK/UL20p were predicted based on the results of experiments which
tagged the suspected intracellular and extracellular domains with epitopes [5, 176]. gk
plays a role in viral fusion since gBΔsyn28 mutation, which is known to cause extensive
virus-induced cell fusion, was inhibited in absence of amino terminus of gK (gKΔ31-68
mutation) pointing out the interdependence and interaction between gK and gB [5].
Mutation of UL20 gene by deletion has resulted in weakly syncytial plaques in some cell
lines and also affected proper envelopment showing the importance of gene with regard
to cell fusion and virion morphogenesis [176]. So the role of both genes in virus-induced
cell fusion was shown by proving the protein-protein interaction between UL20p and
amino terminus of gK with gB in infected cells [185].
Studies have found that UL20 null virus accumulate in the space between nuclear
membranes in certain types of cells like Vero and HEp-2. However, in the case of 143TK
cells virions reach the cytoplasm. This phenomenon depended upon the presence or
absence of intact Golgi networks. Cells complemented UL20-null virus was able to
maintain intact Golgi network, while the network in those that failed in complementation
were fragmented and dispersed [186]. The role of UL20p in fusion is reiterated by the
absence of fusion event in syncytial mutants of gB or gK [179] and also UL20p is
required for cell surface expression of gK [177-179]. Deletion of UL20 or lethal UL20
mutations affects envelopment and leads to accumulation of a few completely enveloped
capsids in the cytoplasmic vesicles and also unenveloped capsids in the cytoplasm of
infected cells [172, 179].
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cytoplasmic virion envelopment and egress. When single, double or triple mutant viruses
were generated deleting these membrane proteins, the most defective ones in terms of
cytoplasmic envelopment, egress, and production of infective viruses were the mutants
with deletion of gK or UL20p [2]. There are other herpes proteins with which UL20p
interact and functions in various steps in the life-cycle of the virus. Apart from its role in
egress and envelopment, UL20p can also modulate virus-induced fusion since the protein
can physically interact with major fusogenic protein gB as proved by two-way
immunoprecipitation studies [185]. UL20p pairs with another important membrane
glycoprotein gK and this is supported by the lack of cell surface expression of gK as well
as cellular fusion mediated by gK in UL20-null mutant virus infected cells [179].
Colocalization of the proteins in confocal microscopy showed the proteins were
interdependent for intracellular transport, cell surface expression and localization at the
TGN, virus-induced cell fusion, and cytoplasmic virion envelopment [176-179]. The
physical interaction between them most likely is between-terminal portion of UL20p with
cytoplasmic gK domain III and has been shown through glutathione S-transferase (GST)
pull down experiments and reciprocal coimmunoprecipitation method. It was also shown
that retention of UL20p in the ER leads to retention of gK pointing out that may be their
transport is interdependent on each other and also UL20p retention prevents cytoplasmic
virion envelopment and virus-induced cell fusion [180]. Studies showed that proteins
UL20p and UL11 are transported independently to TGN, but UL20p functions precedes
and are required for UL11 function in the cytoplasmic virion envelopment [187].
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Glycoprotein B (gB)
The most highly conserved protein in the core fusion machinery among all herpes viruses
is glycoprotein B (gB) and the crystal structure reiterates the fusogenic character of the
protein [119]. The protein is made of 904 amino acids [188]. In addition to binding with
heparin and heparan sulfate, paired immunoglobulin-like type 2 receptor (PILRα) can
function as a receptor for gB for viral entry as well as for fusion, but the glycoprotein D
should also bind to its respective receptor [106, 189]. There is a 30-amino acid residue Nterminal signal sequence which is cleaved during processing, external domain made of a
743-residue, transmembrane domain of 22 amino acids and a 109-residue cytoplasmic
domain [188, 190]. There is structural similarity with fusion proteins of vesicular
stomatitis virus (VSV) G and baculovirus gp64 [191, 192]. In case of Epstein-Barr virus
(EBV) protease cleavage is required to activate the protein, but in case of HSV this has
not yet been proved [193]. It is believed that low pH in the endosomes may be helping gB
in reaching the fusogenic form in HSV [194].
Glycoprotein C (gC)
In HSV-1 gC play an important role in attaching to its receptor heparan sulfate (HS) and
chondroitin sulfate (CS) [195, 196]. Open reading frame of gC is made of 511 amino
acids with a hydrophobic signal sequence, a hydrophobic membrane anchoring sequence
and has 9 sites for N-linked glycosylation [197]. Molecular weight of gC calculated by
SDS-PAGE is around 130kD, but from amino acid sequence is only 55kD and this
difference is due to N-linked oligosaccharides [198], and O-linked oligosaccharides
[199]. This heavy glycosylation is important for the protein to act as the receptor for the
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complement factor c3b [200]. It was shown that the protein requirement in the life-cycle
of HSV-1 is dependent on cell types, as gC is not essential for binding of virus to Vero
cells and its replication was similar to wild-type in Vero, BHK and epithelial cells [201],
whereas in case of mammalian neurons lack of gC reduced efficiency in replication to 510 fold when compared to wild-type [202]. gC can act as an immune modulator by
inhibiting complement cascade by binding to C3b, a pivotal component of classical and
the alternative complement pathways [203] and preventing binding of C5 and properdin
to C3b [204].
Glycoprotein D (gD)
gD is a type I integral membrane glycoprotein made of 394 amino acids and cleaving of a
signal peptide of 25 amino acids during processing yield a mature protein of 369 amino
acids [205]. There are 3 sites for N-linked glycosylation [205, 206], o-linked
oligosaccharides [207] and a hydrophobic transmembrane anchor sequence near the
carboxy terminus [208, 209]. Several labs were able to show that gD can act as a ligand
for HSV receptor. For instance, inactivated wild-type virions blocked infection with
HSV, but UV-inactivated virions lacking gD failed in inhibiting infection [210]. Then
scientists have shown that wild-type HSV failed to infect gD expressing cells [211]. This
inhibition is based on the structure of the protein in the infecting virus and occurs during
the step of penetration [212-214]. Finally, infection is prevented when cells are incubated
in the presence of soluble truncated gD [215-217]. Native conformation is critical for gD
function and is not dependent on the three N-glycosylation [218-220]. Cell surface has
many receptors for gD for allowing entry of HSV [221].
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The herpesvirus entry mediator (HVEM), the first herpes receptor found is a member of
Tumor Necrosis Factor Receptor (TNFR) family and is used by both type 1 and type 2 of
HSV [222]. HVEM has low levels of expression on fibroblasts and on ocular tissue [223,
224]. Whereas, Nectin-1 receptor is for both type 1 and 2 on neurons are present on
keratinocytes, and epithelial cells [224]. Heparan sulfate (HS) modified by 3-Osulfotransferases (3-OS-HS) can also act as a receptor for gD [225].
Glycoprotein G (gG)
US4 gene made of 716 bp encodes 238 aa glycoprotein G (gG). The function of
glycoprotein G has been a difficult task to explore. Studies have shown that mutations in
the gene whether deletion or insertions did not affect the replication of virus in
nonpolarized cells [226, 227].Whereas, in case of polarized cells viral gG is required for
efficient infection of apical membranes of the cells and gG deleted mutant infected basal
membranes similar to wild-type virus. The first surface virus getting exposed is the apical
membranes of epithelial cells on the mucosal surface of the susceptible host. On the other
hand, scarification of corneas allowed viral exposure to other cell surface and gG deleted
virus could infect as similar to wild-type virus [228].
Glycoprotein E and I (gE/gI)
gE/gI is a heterodimer and have extracellular portions and cytoplasmic regions made of
100 amino acids have tyrosine motifs, dileucine, acidic clusters which may tend to
localize the protein in the trans-Golgi network [229, 230]. gE and gI are found bound to
each other and formation of a heterodimer happen quickly and they function as a complex
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[231, 232]. The protein complex has a very important role to play with regard to spread
of virus between tight junctions of neighboring cells especially in case of epithelial cells,
fibroblasts, and neurons. The heterodimer localized on the lateral surfaces of epithelial
cells, but was absent on both apical and basal surfaces. In case of less confluent cell
culture monolayers, gE/gI was found at cell junctions but lacked completely on lateral
cell surfaces which were not in contact with adjacent cells [233].There was spread defects
in mutant HSV-1 viruses lacking gE or gI in epithelial and neuronal cell cultures [233,
234]. A study have shown that in corneal cells there was a spread defect of 4 to 6 % on
epithelial cells when compared to the wild-type HSV virus [235]. Spread among
susceptible cells is through sorting of new progeny virions to lateral cell surface and cell
junctions [236]. In an experiment when the entire gE protein or the cytoplasmic (CT)
domain of the protein was deleted caused accumulation of virions in the cytoplasm, at the
apical surfaces, and also in cell cultural supernatants whereas in case of wild-type virus
accumulation was concentrating at cell junction. This showed the importance of
cytoplasmic domain of gE protein in cell-cell viral spread [237]. Apart from spread the
heterodimer functions include immune evasion and virulence [238-240].
Glycoproteins H and L (gH/gL)
The most important glycoproteins for viral entry and fusion among herpesviruses other
than gB and gD are glycoprotein H (gH) and L (gL). Both gH and gL are required for
posttranslational modifications and transport. Studies have shown that if only gH is
expressed, then the protein processing is affected and the misfolded protein is trapped
intracellulary [241]. Similarly, for proper expressions and posttranslational modifications
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of gL is dependent on gH. Since gL lacks any hydrophobic domain to act as a membrane
anchor, the association with gH may be helping the protein to remain membrane
associated [242]. Another school of thought is that the hydrophobic amino terminus act as
a membrane anchor and also as a signal peptide. gH is a type 1 membrane protein with
the signal sequence directing it to the biosynthetic pathway and the transmembrane
domain of the protein helps in attaching gH/gL protein complex to the membrane [243].
There have been emphasis on specific amino acids on the cytoplasmic domain of gH
required for membrane fusion [244]. Antibodies to gH inhibited both cellular spread and
virus infectivity [245], while antibodies to gL only affected cellular fusion and not virion
infectivity [246]. Neutralizing antibodies were made when mice were vaccinated with
gH/gL complex and the vaccinated group showed less primary infections and upon
challenge there were no secondary lesions [247].
Glycoprotein J (gJ)
Glycoprotein J is encoded by US5 gene and their major function is in the ability to inhibit
apoptosis [248]. It was in 1998 the ability of US9 genes sequence to encode gJ was
demonstrated [249]. Soon it was shown that the us9 deletion abolished UV- or anti-fasinduced apoptosis [79]. The gene is initially expressed 4h after infection and can be
detected at 6 h after infection. There are two forms, glycosylated and unglycosylated. The
distribution was bound to endoplasmic reticulum, trans-Golgi network and early
endosomes. Further works were able to show that just the expression of gJ can protect
infected cells from apoptosis induced by cytotoxic T lymphocyte killing mechanism
[248]. The protein is produced in limited quantities and localizes to membranes in the
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cells. gJ can produce reactive oxygen species (ROS) in transfected and infected cells and
may be influencing HSV lifecycle in different ways [250].
Glycoprotein M (gM)
The glycoprotein M (gM) is a hydrophobic type III membrane protein of 475 amino acids
encoded by the UL10 gene. It has eight transmembrane domains with amino and carboxy
termini directed towards cytosol [251, 252]. The open reading frame of the gene has two
sites for N-linked glycosylation, one at the amino acid position 71 and the other at amino
acid position 247. The first site is conserved among homologs of the gene in human
cytomegalo virus (CMV) and varicella-zoster virus [253]. gM localizes to ER in infected
cells [254]. The protein is highly hydrophobic and aggregates when boiled with buffers
having SDS similar to UL20 protein [165, 251]. gM has also shown moderate
antagonistic activity against tetherin, an antiviral effector that tethers newly enveloped
virions to cell membrane preventing the egress [255]. Even though the gene is highly
conserved among the members of family herpesviridae, it is a non-essential gene for
HSV-1 [256], pseudorabies virus (PRV) [257], bovine herpes virus type 1 [258],
Varicella-zoster virus [259], infectious laryngotracheitis virus [260], equine herpes virus
type-1 (EHV-1) [261], and EHV type 4 [262]. In HSV-1, deletion of gM leads to small
reduction in viral replication titers and smaller plaque sizes [169, 256]. gM can redirect
other glycoproteins like gD and gH/gL to TGN following transfection due to the presence
of classical endocytic signals at the carboxyl terminus [263]. Interaction between gM and
VP22 encoded by UL49 has also been demonstrated [264]. gM can also associate with
another membrane glycoprotein gN in various herpes viruses [265-268].
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Glycoprotein N (UL49.5)
The open reading frames of HSV-1 and HSV-2 UL 49.5 is comprised of 91 and 87
codons respectively and protein has a transmembrane domains and expressed from a Y2
transcript [269, 270]. In case of PrV UL49.5 protein is made of 98 amino acids with the
molecular weight around 10 kDa and have a signal peptide. The molecular mass will be
reduced by 2 kDa if the signal sequence is cleaved. In HSV-1 the UL49.5 gene is
separated from UL50 by 23 bp. This gene is conserved in Varicella zoster virus (VZV)
[271].
Tegument Proteins
Initially HSV-1 virion proteins including tegument proteins were named viral protein 1
(VP1) to viral protein 24 (VP24) on the criteria of migration on a denaturing protein gel
[272, 273]. Later tegument proteins were named based on the open reading frames and
are called unique short (US) or unique long (UL) with prefix p in order to distinguish
between a protein and a gene. The total number of tegument proteins determined by
proteomic analysis in HSV-1 is 23 [274]. Some of the tegument proteins like pUL46
(VP11/12), pUL47 (VP13/14), pUL48 (VP16), and pUL49 (VP22) are abundantly
present with copy numbers ranging from 1000-2000 copies. The four tegument proteins
critical for viral growth in cell lines are pUL36 (VP1/2), pUL37, pUL48 and ICP4 [275].
During entry of virus to nonneuronal cells most of the envelop as well as tegument
proteins are lost and nucleocapsids with a few inner tegument proteins reach host cell
nucleus [276, 277]. It has been confirmed that the inner tegument proteins pUL36 and
pUL37 are conserved among the herpesviridae family and associated with capsids after
entry to Vero cells [278]. The incoming HSV-1 nucleocapsids depend on microtubular
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transport based on dynein/dynactin complex to reach nucleus. The most suspected
candidates for interacting with dynein motor proteins are pUL36 and pUL37, though
nobody has yet proved through experiments [279]. Multiple studies have shown the
importance of pUL36 in directing nucleocapsids to the nuclear pore complex (NPC) for
the release of viral DNA [280-282]. Another tegument protein pUL14 has also been
shown in targeting capsids to the nucleus [283]. pUL48 plays role in the formation of
transcriptional complex and for formation of new virions [284]. Virion host shut-off (vhs)
proteins (pUL41) inhibit both host and viral protein synthesis by degrading mRNA [285].
pUS11 binds to dsRNA through RXP repeats and interacts with nucleoli and ribosomes
[286] and inhibit cellular protein synthesis through regulation of protein kinase Ractivated host protein shutoff and decay of mRNA [287]. For envelopment and egress,
virions require both pUL36 and pUL37 which are conserved among members of
Herpesviridae family [288].

Both these proteins along with pUS3 forms the inner

tegument layer of the newly formed nucleocapsids in the cytoplasm [289]. It has been
shown that transport of pUL37 to golgi is affected in the absence of pUL36 in a capsidindependent manner [290]. It has been shown that pUL37 is only essential for replication
of HSV-1, whereas in PrV they require both proteins UL36 and UL37.
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CHAPTER III
PHENYLALANINE RESIDUES AT THE CARBOXYL-TERMINUS OF THE
HERPES SIMPLEX VIRUS TYPE-1 UL20 MEMBRANE PROTEIN
REGULATE CYTOPLASMIC VIRION ENVELOPMENT AND
INFECTIOUS VIRUS 1 PRODUCTION
Importance
The herpes simplex virus type-1 (HSV-1) UL20 gene encodes a 222 amino acid long
non-glycosylated envelope protein which forms a complex with viral glycoprotein K
(gK) that functions in virion envelopment, egress, and virus-induced cell fusion. To
investigate the role of the carboxyl-terminus of the UL20 protein (UL20p) in cytoplasmic
virion envelopment, a cadre of mutant viruses was constructed and characterized.
Deletion of six amino acids from the carboxyl terminus of UL20p caused approximately
one-log reduction in infectious virus production compared to the wild-type virus.
Surprisingly, a phenylalanine-to-alanine replacement at amino acid position 210 caused a
gain-of-function phenotype increasing infectious virus production up to one log more
than the wild-type virus. In contrast, replacement of two membrane proximal
phenylalanines with alanines caused drastic inhibition of infectious virion production and
cytoplasmic virion envelopment. Prediction of the membrane topology of UL20p
revealed that these two amino acid changes cause retraction of the carboxyl-terminus of
UL20p from the intracellular space. Confocal microscopy revealed that all the engineered
UL20 mutations did not affect intracellular transport of UL20p to trans-Golgi Network
membranes.

1

This chapter previously appeared as Charles et al., 2014. Phenylalanine residues at the carboxyl-terminus
of the Herpes Simplex Virus type-1 UL20 membrane regulate cytoplasmic virion envelopment and and
infectious virus production. J Virol. 2014 Jul 1;88(13):7618-27. It is reprinted with the permission of
American Society of Microbiology.
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In addition, proximity ligation assay showed that none of the UL20 mutations affected
UL20p colocalization and potential interactions with the UL37 protein recently found to
interact with the gK/UL20 protein complex. Collectively, these studies show that
phenylalanine residues within the carboxyl terminus of UL20p are involved in the
regulation of cytoplasmic virion envelopment and infectious virus production.
We have shown that the UL20/gK protein complex serves crucial roles in cytoplasmic
virion envelopment and that it interacts with the UL37 tegument protein to facilitate
cytoplasmic virion envelopment. In this manuscript, we investigated the role of
phenylalanine residues within the carboxyl terminus of UL20p, since aromatic and
hydrophobic amino acids are known to be involved in protein-protein interactions
through stacking of their aromatic structures. Characterization of mutant viruses carrying
phenylanine (phe) to alanine (ala) mutations revealed that the two membrane proximal
phe residues were critical for the proper UL20p membrane topology, and efficient virion
envelopment and infectious virus production. Surprisingly, a phe-to-ala change located
approximately in the middle of the UL20p carboxyl terminus substantially enhanced
cytoplasmic envelopment and overall production of infectious virions. This work
revealed that phe residues within the UL20p carboxyl terminus are involved in the
regulation of cytoplasmic virion envelopment and infectious virus production.
Introduction
Herpes Simplex Virus type 1 (HSV-1) is a neurotropic herpes virus that after replication
in epithelial cells enters into ganglionic neurons via distal axons and establishes latent
infection [1]. HSV-1 is the primary infectious cause of blindness in the western
hemisphere primarily because periodic reactivation causes recurrent keratitis and scarring
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of cornea [2, 3]. Herpes virus particles consist of a linear double-stranded DNA genome
containing an icosahedral capsid, surrounded by a proteinaceous tegument, and an
outermost cell-derived lipid envelope. The virus encodes at least eleven glycosylated and
several non-glycosylated proteins expressed on the viral envelope and in infected cell
membranes, which are important for the life cycle of the virus especially during virus
entry, intracellular virion morphogenesis and cell-to-cell spread. HSV-1 virion
morphogenesis and egress involves complex mechanisms, which are characterized by
sequential morphogenetic steps including: a) primary envelopment of capsids at the inner
nuclear membrane; b) de-envelopment of enveloped capsids at the outer nuclear
membrane; c) acquisition of tegument proteins in the cytoplasm of infected cells; d) reenvelopment of tegumented capsids at the TGN-derived membranes [4-6]. Cytoplasmic
virion envelopment is facilitated by multiple interactions among viral glycoproteins
embedded in TGN membranes and tegument proteins [6-10].
The UL20 gene encodes a 222 amino acid long non-glycosylated envelope protein, which
plays a crucial role in cytoplasmic virion envelopment and egress of HSV-1. The UL20
gene is highly conserved among alphaherpesviruses including varicella-zoster [11],
pseudorabies virus (PRV) [12] and the gammaherpesvirus Marek's disease virus type 2
[13]. The UL20 protein has been shown to be important for infectious virion production
for both PRV and HSV-1 [14, 15]. The UL20 protein forms a functional complex with
glycoprotein K (gK), which physically binds with gB and gH to modulate virus-induced
cell fusion [16].
Deletion of 18 amino acids from the carboxyl terminus of UL20p (UL20 mutant virus
204t) inhibited intracellular transport and cell surface expression of both gK and UL20p,
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and failed to complement infectious virus production. On the other hand, deletion of
either 6 (UL20 216t) or 11 amino acids (UL20 211t) allowed efficient UL20p and gK
intracellular transport and cell surface expression, but failed to complement for infectious
virus production [17]. Phenylalanine residues are aromatic and hydrophobic amino acids
that are known to be involved in protein-protein interactions and have been shown to play
an important role in respiratory syncytial virus assembly [18]. Therefore, we sought to
determine the potential role of phenylalanine residues in the carboxyl terminus of UL20p
in cytoplasmic virion envelopment and egress under the hypothesis that cytoplasmic
domains of UL20p may interact with tegument proteins to facilitate cytoplasmic virion
envelopment. The UL37 protein is a 120 kDa phosphorylated protein [19] that assumes a
predominantly diffused cytoplasmic distribution in infected cells [20-22] and can be
transported to TGN membranes as a complex with the UL36 protein in the absence of
capsid formation [23]. The UL37 tegument protein specified by HSV-1 and PRV has
been shown to play an important role in cytoplasmic virion envelopment, since deletion
of the UL37 gene resulted in accumulation of capsids in the cytoplasm of infected cells
[24-26]. Recently, we showed that the HSV-1 UL37 protein interacts with gK and UL20p
to facilitate cytoplasmic virion envelopment [27]. Herein, we show that a UL20
phenylalanine residue at position 210 plays a critical regulatory function in cytoplasmic
virion envelopment and infectious virus production, as evidenced by the surprising one
log higher infectious virus production of the mutant virus containing a phe to ala
substitution at aa residue 210, when compared to wild-type virus. Moreover, two other
phenylalanine residues proximal to the membrane of the carboxyl-terminus of UL20p are
required for proper UL20p membrane topography and function. These phenyalanine to

63

alanine mutations did not appreciably alter the co-localization and potential interactions
with the UL37 protein suggesting that they do not play major roles in the overall
interactions between the UL37 protein and the gK/UL20 protein complex.
Materials and Methods
Cells.
African green monkey kidney (Vero) cells were obtained from the American Type
Culture Collection (Rockville, MD) and Vero based UL20 Protein complementing FRT
Cells were maintained in Dulbecco's modified Eagle's medium (Gibco-BRL; Grand
Island, N.Y.) supplemented with 10% fetal calf serum and antibiotics.
Construction of HSV-1 mutant viruses
Mutagenesis was accomplished in Escherichia coli using the markerless two-step Red
recombination mutagenesis system and synthetic oligonucleotides [28, 29] implemented
on the bacterial artificial chromosome (BAC) plasmid pYEbac102-VC1 carrying the
HSV-1(F) genome with proteins gK and UL20 tagged with V5 and 3xFLAG antigenic
epitopes, respectively. Unless otherwise specified, the wild-type virus used in all
experiments is the VC-1 strain. HSV-1 mutants UL20∆6 and UL20∆Phe were
constructed by adding a stop codon TAA in front of last amino acid or last 6 amino acids
from the carboxyl end of UL20p respectively. Whereas, mutants UL20F222A,
UL20F210A, and UL20F205-206A were created by changing codons for Phenylalanine
at respective positions to Alanine codon GCA (Table 1). HSV-1 BAC DNAs were
purified from 50 ml of overnight bacterial cultures with a Qiagen large-construct kit
(Qiagen; Valencia, CA). Using PCR test primers designed to lie outside the target
mutation site (s), all mutated DNA regions were sequenced to verify the presence of the
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desired mutations in BACs. Similarly, viruses recovered from cells transfected with
BACs [28] were sequenced to confirm the presence of the desired mutations. The entire
genomes of the wild-type and the UL20F210A mutant viruses were sequenced using the
Ion Torrent Next Generation Sequencing equipment (Life Technologies-Invitrogen;
Carlsbad, CA), as we have described previously [30]. Briefly, total genomic DNA
(gDNA) was extracted from the virus-infected Vero cells using the PureLink Genomic
DNA Mini Kit (Life Technologies-Invitrogen; Carlsbad, CA). High-quality fragment
libraries of each virus were prepared from the extracted total gDNAs using the Ion
Xpress Plus Fragment Library Kit (Life Technologies-Invitrogen; Carlsbad, CA). The
fragment libraries were subsequently applied to Ion 316 chips and were sequenced on the
Ion Personal Genome Machine System (Life Technologies-Invitrogen; Carlsbad, CA).
SDS-PAGE and Western Immunoblot Assay
Western immunoblot analysis was carried out essentially as described earlier [31].
Confluent monolayers of Vero cells were infected with the indicated viruses at an MOI of
2. At 24 hpi, cells were washed with PBS and lysed on ice for 30 min in NP-40 lysis
buffer (Life Technologies) supplemented with a cocktail of protease inhibitors (Roche,
LLC, Basel, Switzerland). The collected samples were mixed with SDS-PAGE sample
buffer (NuPAGE) at 3:1 ratio and were electrophoretically separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (Tris-HEPES-SDS gradient 4-20% gels,
Thermo scientific). Following electrophoresis, the proteins were transferred onto a
nitrocellulose membrane under a constant current. Membrane was blocked in Phosphatebuffered saline containing 0.1% Tween 20 (PBST) plus 5% nonfat milk for 1 hour at
room temperature (RT) and was probed with primary mouse anti-Flag mAbs (Abcam;
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Cambridge, England) for over-night at 4°C. Goat anti-mouse secondary antibody
conjugated with HRP and Immobilon chemiluminescent HRP substrate (Millipore) were
used for detection purposes.
Plaque Morphologies, Replication Kinetics and Electron Microscopy.
For plaque morphology, confluent monolayers of Vero or FRT cells were infected at a
MOI of 0.001 with the viruses and fixed with methanol 48 h post infection.
Immunohistochemistry was performed with primary rabbit anti-HSV antibodies (1:1,000)
(Dako) and goat anti-rabbit horseradish peroxidase-labeled antibody (1:1,000) (Dako),
and the reactions were developed using the NovaRed substrate (VectorLabs). Images
were taken with an inverted light microscope (Olympus) using relief contrast. Growth
kinetics studies of viruses were performed as we have described earlier [32, 33].
Approximately 90% confluent Vero cells were infected with each virus at 4°C for 1 hour
at a low or high multiplicity of infection (MOI) of 0.2 or 2 respectively. Afterwards,
plates were incubated at 37°C for 1 hour to allow virus penetration. Any remaining
extracellular viruses were inactivated by low pH treatment using PBS at pH 3 and plates
were incubated till its time point and subsequently stored at -80°C till the virus titers were
obtained by endpoint titration on FRT cells. The ultrastructural morphology of virions
within infected cells was examined by transmission electron microscopy as described
previously [16, 28, 32, 34]. All flasks with infected cells were incubated at 37°C and 5%
CO2 until processed at 18 hours post infection (hpi) and infected cell samples were
visualized by transmission electron microscopy.
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Quantification of cell-to-cell fusion
Chemiluminescence-based assay system was used to quantify cellular fusion during viral
infection [35-37]. Around 80-90 % confluent Vero cells in 12-well plates were
transfected separately with plasmids expressing T7 polymerase gene or luciferase gene
under the T7 promoter at amounts 1µg/well each. Lipofectamine 2000 (Invitrogen) was
used for all transfections. Media was changed six hours post-transfection and after 12
hours of incubation at 37°C and 5% CO2, cells were detached using trypsin-EDTA. Both
populations of cells were washed, further resuspended in complete medium and mixed in
1:1 ratio prior to seeding in 24-well plate. Fifteen hours post seeding cells were infected
at a MOI of 0.5. At 24 hpi cells were washed with PBS, lysed with lysis buffer and
supernatants were collected. Supernatant was mixed with luciferase assay substrate and
the amount of relative fusion was obtained by measuring the relative level of
luminescence (RLU) emitted measured using TD-20/20 luminometer (Turner Designs).
Quantitative PCR
Quantitative PCR (qPCR) was utilized to derive the total number of viral genomes within
the lysate. Specifically, the primers and probe (6-carboxytetramethylrhodamine
[TAMRA]) for the real-time PCR were designed to detect HSV-1 US6 (gD). Lysates
were collected at 18 hpi, and 200 μl of each suspension was used for the extraction of
viral DNA. Viral DNA was extracted using a DNeasy blood and tissue kit (Qiagen, Inc.)
as per the manufacturer's instructions. Equal volumes of viral DNA were used for
TaqMan PCR analysis. Purified HSV-1 bacterial artificial chromosome (YE102) DNA
was used to generate the standard curve.
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Confocal Microscopy
Vero cell monolayers grown on eight-well glass Lab-Tek II chamber slide were infected
with the indicated virus at an MOI of 10. Uninfected cells were used as negative controls.
Cells were washed once with PBS and fixed with ice-cold 100% methanol for 10 minutes
at 18 hpi. Monolayers were subsequently blocked for 1 h with 2% fetal calf serum in
PBS. Further staining was done using mouse monoclonal anti-FLAG IgG1 (SigmaAldrich, St. Louis, MO) for recognition of UL20p and TGOLN2 IgG2a (Abnova,
Taiwan) for recognition of trans-Golgi network diluted 1:200 in PBS blocking buffer
followed by Alexa Fluor 555-conjugated goat anti-mouse IgG1 and Alexa Fluor 488conjugated goat anti-mouse IgG2a secondary antibodies. Nucleus was stained using 4′, 6diamidino-2-phenylindole (DAPI). Specific immunofluorescence was examined using an
Olympus FluoView confocal microscope. Image analysis and subcellular scatter plot
graphs were generated and analyzed using the Olympus FluoView FV1000 confocal
microscope software interface. Scatterplot graphs with colocalization of two fluorophores
within the TGN were generated by specifically defining the regions of interest with a
bounding box of equal area based on pixel enumeration for each captured image. To
determine an approximate percentage of subcellular colocalization, pixel enumeration
and intensity statistics within the Olympus software package were accumulated for each
sample image. The percentage of upper right quadrant pixels from the total sample pixels
was displayed. Finally images were compiled and rendered with Adobe Photoshop.
Proximity Ligation Reaction (PLA)
In situ PLA detection was carried out using the appropriate DUOLINK II In Situ kit
components obtained from Sigma-Aldrich, St. Louis, MO. Vero cell monolayers grown
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on eight-well glass Lab-Tek II chamber slide were infected with the indicated viruses at a
MOI of 10. At 18 hpi cells were fixed using methanol for 10 minutes and blocked using
DUOLINK blocking solution at 37°C in a wet chamber for 2 h. Primary antibodies used
are anti-FLAG mouse (Sigma-Aldrich, St. Louis, MO) and anti-UL37 rabbit for the
negative controls (mock infection and untagged wild type F strain) and for the wild type
as well as the mutants. Whereas, primary antibodies used for positive control (gK-UL20p
interaction) are anti-V5 mouse (Invitrogen Life Technologies) and anti-FLAG rabbit
(Sigma-Aldrich, St. Louis, MO). Antibodies were diluted in blocking buffer and
incubated in a wet chamber at 4°C overnight. The slides were washed two times with 1X
TBS + 0.05% Tween 20 for 5 min each, then secondary antibodies (DUOLINK antirabbit PLA-plus probe, DUOLINK anti-mouse PLA-minus probe) were added and
incubated at 37°C for 1 h. Two washes with Duolink In situ wash buffer A for 5 min each
were then followed by addition of the ligation mix and incubation in wet chamber at
37°C for 30 min. After ligation slides were washed twice for 2 min using Duolink In situ
wash buffer A before adding amplification reaction mix for 90 min at 37°C. Texas red–
labeled oligonucleotide detection probes (Olink Bioscience) were used. Subsequently, the
slides were washed twice with Duolink In situ wash buffer B, and once with 0.1×
Duolink In situ wash buffer B. Slides were mounted with Duolink In Situ Mounting
Medium with DAPI and analyzed in a Olympus FluoView confocal microscope.
Results
Construction and Molecular Analysis of recombinant viruses
We have previously shown that deletion of the UL20p carboxyl terminal six-amino acids
resulted in drastic inhibition of cytoplasmic virion envelopment and egress [17]. To
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further investigate the potential role of phenylalanine residues within the carboxyl
terminus of the UL20 protein, we constructed a cadre of mutant viruses for which one or
more phenylalanine residues were replaced with alanine residues. All mutant viruses
were constructed using the markerless two-step Red recombination mutagenesis system
implemented on the bacterial artificial chromosome (BAC) plasmid pYEbac102-VC1
carrying the HSV-1(F) genome (see Materials and Methods). This virus expresses gK and
UL20p tagged with V5 and 3xFLAG antigenic epitopes, respectively [30, 38]. The
recombinant mutants included viruses having a deletion of the terminal phenylalanine
residue (UL20∆Phe), deletion of six amino acids from the carboxyl terminus (UL20∆6),
and replacement of one or two internal phenylalanine residues with alanines
(UL20F222A, UL20F210A, and UL20F205-206A) (Fig. 3.1 and Table 3.1). The deletion
mutants were made by the insertion of stop codon TAA in front of the last amino acid for
UL20∆Phe and before the last 6 amino acids for UL20∆6. Similarly, for the amino acid
replacement mutants, codons for phenylalanine (TTT or TTC) were replaced with the
codon for alanine (GCA). Virus stocks were prepared after BAC transfection on FRT
cells. Mutant viral genomes were characterized using PCR-assisted DNA sequencing, as
well as whole genome sequencing approaches (see Materials and Methods section).
Replication and Phenotypic characteristics of the mutant viruses
The plaque morphologies of all mutant and wild-type viruses were examined on Vero
cells (Fig. 3.2a) and FRT cells (Fig. 3.2b). As expected, the HSV-1(VC1) wild-type virus
produced the largest virus plaques, while the UL20F205-206A, UL20∆6 produced
smaller viral plaques when compared to the parental wild-type virus on Vero cells, while
the recombinant viruses UL20∆Phe, UL20F222A produced syncytial plaques on Vero
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cells (Fig. 2a).

All mutants produced wild-type-like plaques on FRT (Vero cells

transformed to express the UL20 gene) cells (Fig. 2b). Western immunoblot analysis
revealed that all viruses expressed similar levels of the UL20 protein (Fig. 3.3). To
investigate the role of these mutations on the kinetics of viral replication, replication
curves were produced for infections at both low (0.2) and high (2) MOI (Fig.3.4a, b). At
both high and low MOI, the UL20F205-206A mutant yielded the lowest end titer and
UL20F210A mutant yielded the highest end titer when compared to wild-type virus.
Importantly, the UL20F210A virus reproducibly produced approximately one log higher
viral titers, when compared to the wild type virus at high MOI. At low MOI of 0.2,
terminal viral titers of UL20∆6 and UL20F205-206A were 1 and 2 logs less, respectively
in comparison to wild-type, while the UL20F210A mutant virus produced significantly
higher viral titers than the wild-type virus. At MOI 2, the UL20F205-206A mutant virus
titer was more than a log less than the wild-type virus.
Quantification of cell-to-cell fusion.
Mutant viruses UL20∆Phe and UL20F222A produced syncytial plaques on Vero cells.
The extent of virus-induced cell fusion was evaluated using a previously described
luciferase assay [30] (see Materials and Methods). The gBΔ28syn mutant HSV-1 virus
carrying a 28 amino acid deletion of the carboxyl terminus of gB causes extensive virusinduced cell fusion [31] and was used as positive control. The relative levels of
luminescence were measured for all samples at 24 hours hpi. Among mutant viruses, the
UL20F222A produced the highest extent of fusion exhibiting RFU levels that were
similar to those of the positive control gBΔ28syn virus (Fig. 3.5).
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degrees of cytoplasmic defects in virion envelopment, as evidenced by the presence of
numerous unenveloped or partially enveloped capsids in the cytoplasm of infected cells
(Fig. 3.6).
Characterization of the relative efficiency of cytoplasmic virion envelopment
A measure of the relative efficiency of infectious virion production is indicated in the
ratio of total viral genomes produced in infected cells to the number of infectious virions
determined by the standard plaque assay. In this regard, The UL20F205-206A mutation
caused the most severe defect in the relative efficiency of infectious virion production
followed by UL20∆6 mutant virus (Table3. 2).
Intracellular localization of the UL20 mutant proteins and UL20 interactions with
the UL37 protein
The intracellular location of wild-type and mutant UL20 proteins was investigated using
confocal microscopy. All mutant viruses expressed UL20p that colocalized with the TGN
marker TGOLN2. These visualization results were further supported by determination of
the approximate percentage of subcellular co-localization using pixel enumeration and
intensity statistics as detailed in Materials and Methods (Fig. 3.7). Recently, we showed
that the UL37 protein physically interacted with the gK/UL20 protein complex to
facilitate cytoplasmic virion envelopment. To investigate whether the engineered
UL20mutations affected interactions between UL20p and UL37 proteins, we utilized the
proximity ligation assay [39, 40] in conjunction with the anti-FLAG monoclonal antibody
detecting the UL20-tagged protein and the anti-UL37 polyclonal antibody. The known
interactions between the UL20 protein and gK was also tested using the anti-FLAG
(UL20) and anti-V5 (gK) antibodies, as a positive PLA control. PLA produced vivid
mutations affected interactions between UL20p and UL37 proteins, we utilized the
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Table 3.2. Determination of viral genomes-to-PFU ratios. The total number of viral
genomes infected Vero cells at 24 hpi were obtained by qPCR. The total number of
intracellular infectious virions was obtained by plaque assay on FRT cells. Ratios
reflecting relative efficiency of envelopment and infectious virion production were
obtained by dividing the average of the number of viral genomes within infected cells by
number of PFU.

Viruses

Total HSV-1 genomes/PFU
(in thousands)

Wild- Type

48

UL20∆6

538

UL20∆Phe

170

UL20F222A

166

UL20F210A

38

UL20F205-206A

5648

Discussion
We have previously shown that the gK/UL20 protein complex serves crucial roles in
cytoplasmic virion envelopment [9]. Our laboratory and others have shown that the UL37
protein localizes to the TGN membranes and functions in cytoplasmic virion
envelopment [41]. Recently, we showed that the UL37 protein interacts with the
gK/UL20 protein complex and facilitates cytoplasmic virion envelopment and infectious
virus production [27]. Herein, we show that phenylalanine residues located at the
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carboxyl terminus of the UL20 protein are involved in the regulation of cytoplasmic
virion envelopment and infectious virus production.
We have previously reported the use of extensive alanine-scanning mutagenesis of the
UL20 protein to delineate domains of the UL20 protein that function in cytoplasmic
virion envelopment and virus-induced cell fusion [42]. Specifically, we showed that the
amino terminus of the UL20 protein functioned in virus-induced cell fusion, while the
carboxyl terminus was important for cytoplasmic virion envelopment [42]. Of specific
interest to the current study was that deletion of the terminal six amino acids of the UL20
protein drastically inhibited cytoplasmic virion envelopment, while it did not affect UL20
protein interactions with gK and virus-induced cell fusion [42]. Based on our recent
findings that the gK/UL20 protein complex interacts with the UL37 protein, we
hypothesized that this interaction may occur between the carboxyl terminus of the UL20
protein and the UL37 protein. These interactions may involve phenylalanine residues,
which are known to facilitate protein-protein interactions through residue stacking and
hydrophobic interactions. Significantly, the UL20F210A mutation caused more than one
log higher replication kinetics and final infectious virus production than wild-type virus
on Vero cells at high MOI. Moreover, the ratio of total viral genomes to PFU was lower
than that of the wild-type virus indicating that this mutation increases the efficiency of
infectious virus production. The observed increase in the production of infectious virions
reflects enhanced cytoplasmic virion envelopment, since it is unlikely that UL20
mutations would affect other aspects of virion assembly such as capsid assembly in the
nucleus. Moreover, the UL20F210A mutant virus produced higher infectious virus titers
at high versus low MOI in comparison to the parental wild-type virus suggesting that
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enhancement in infectious virus production is dose-dependent on the expression of the
UL20F210A protein.
The UL20F210A “gain-of-function” mutation reveals that the phenylalanine (210)
residue is involved in regulation of cytoplasmic virion envelopment and infectious virus
production. The purpose of this inhibitory mechanism is not immediately apparent.
Infectious virus titers and particle to PFU ratios are affected by temperature with
optimum virus titers and particle-to-PFU ratios produced at 34°C presumably because the
entire process of virion assembly is more efficient at reduced assembly speed (Kousoulas,
unpublished observations). Thus, it is possible that the process of cytoplasmic virion
envelopment is down-regulated by UL20/gK to ensure efficient virion envelopment at
37°C or higher. Alternatively, the replacement of the phenylalanine (210) may cause
more efficient interaction of UL20p with other viral proteins or cellular proteins involved
in cytoplasmic virion envelopment.
The UL20F222A mutant virus caused extensive virus-induced cell fusion on Vero cells,
which was completely inhibited on the UL20 complementing FRT cells. This result
suggests that the phenylanine residue at amino acid position 222 is involved in the
regulation of membrane-fusion presumably because it alters the interactions of the
gK/UL20 protein complex with the fusogenic glycoprotein gB.

All mutant viruses

produced similar plaques with respect to size and fusogenic characteristics on FRT cells
indicating that wild-type UL20p expression by FRT cells efficiently reverted all mutant
phenotypes to that of the wild-type. Overall, these results suggest that the wild-type
UL20p expressed by the FRT cells acts in a dominant manner to reverse the effect of
these UL20 mutations presumably because it interacts more efficiently with gK, gB and
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UL37. Reversion of the phenotypic and growth properties of the UL20 mutant viruses
indicates the absence of any other spurious mutations within the mutant viral genomes.
This conclusion is further supported by PCR-assisted sequencing of targeted genomic
areas and genomic sequencing of the wild-type and the UL20F201A genomes by next
generation sequencing methodologies, which did not detect any spurious mutations.
Phenylalanine replacement or deletion of carboxyl terminal regions of the UL20 protein
that contained phenylalanine residues caused drastic defects in virion envelopment
without affecting colocalization of the UL20 mutant proteins with the UL37 protein, as
evidenced by similar PLA-produced fluorescent signals. Of particular interest is the
mutagenesis of two membrane proximal phenylalanine residues to alanines. This double
amino acid replacement is predicted to cause retraction of the carboxyl terminus of the
UL20 protein, so that it is no longer exposed to intracellular spaces (Fig. 3.9). These
results suggest that the carboxyl terminus of the UL20 protein is not a major contributor
to overall interactions with the UL37 protein. Alternatively, mutagenesis of the carboxyl
terminus of the UL20 protein may negatively affect other functional aspects of the overall
interactions of the gK/UL20 complex, as well as its potential domain- specific affinity to
UL37 or other tegument proteins causing inhibition or enhancement of cytoplasmic
virion envelopment and infectious virus production.
Cytoplasmic virion envelopment has been thought to involve a series of complex
interactions between viral glycoproteins embedded in the TGN membranes and
teguments proteins found on cytoplasmic capsids, or bound to TGN membranes. Results,
herein, show that cytoplasmic virion envelopment is a dynamic process where
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certain cells, where the virus may need to control the rate of infectious virus production.
The UL20F210A gain of function mutation can be incorporated into other mutant herpes
viruses engineered for anticancer or gene therapy purpose to enhance their beneficial
functions or to alleviate their defects in replication efficiencies and produce higher titers
of virus. Further studies are required to explore this gain of function behavior of the
mutant virus and to investigate whether the mutation has any effect on the pathogenesis
of the virus in experimental animal infections.
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CHAPTER IV
ENTRY CHARACTERISTICS OF HSV-1 gK 31-68 MUTANT IN VERO CELLS
AND NEURONS STUDIED USING UL37 PROTEIN/DYNEIN PLA ASSAY
Significance
Cytoplasmic dyneins are known to transport cargoes in a retrograde manner, which is
towards the center of the cell. We show here for the first time utilizing PLA, that in both
epithelial cells and neuronal ganglia, the motor protein dynein potentially interacts with
the HSV-1 inner tegument protein UL37 upon release of the cytosolic capsids in to the
cytosol of the host cell. PLA, is a valuable tool to detect protein-protein interaction that
overcomes the non-specificity of antibody approach or the difficulties associated with coimmunoprecipitation assay when relatively large hydrophobic membrane proteins are
involved. The interaction between UL37 and dynein was seen as early as 30 minutes after
entry and continued till 14 hrs. However, it was considerably reduced and almost
completely absent at 16 hours post entry. This interaction was much pronounced in the
wild type virus after one hour post infection, when compared to the gK 31-68 mutant
virus which has been shown to enter relatively slowly in Vero cells. This clearly implies
that upon losing the envelope on the cell surface, the viral capsids with the tegument
proteins interact with dynein and utilize the microtubular network to be transported to the
nucleus.
Introduction
Herpes Simplex Virus-1 (HSV-1) predominantly enters Vero cells by the fusion
mechanism, where the viral envelope fuses with the cellular plasma membranes in a pHindependent manner. While fusion remains the only mode of entry of HSV-1 in neuronal
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cells[1], entry of the virus in non-neuronal cells can also occur by receptor-mediated
endocytosis where the low pH milieu of the endosomes causes the fusion to takes place
between the viral envelope and the endocytic membranes [2]. Virus-induced cell fusion
mediated by viral glycoproteins helps the virus to spread from infected cells to uninfected
cells without being exposed to extracellular spaces [3].
HSV-1 encodes at least 26 tegument proteins and 11 virally encoded glycoproteins, as
well as several non-glycosylated membrane associated proteins. The viral glycoproteins
gD, gB, gH, and gL have been known to be involved in virion entry, while gC has been
known to enhance initial binding of the virus to host cell membranes [4-8]. The virion
entry is thought to be initiated by the binding of glycoproteins gB and gC to
glycosaminoglycan (GAG) moieties of cell surface proteoglycans [9]. This initial
attachment causes the interaction of gD with one or more of its specific receptors,
including the herpesvirus entry mediator (HVEM,or HveA), nectin-1 (HVeC), 3-oheparan sulfate and additionally PILR-α, NMHC-IIA, and myelin associated
glycoprotein(MAG), that facilitates virion attachment and virus entry[10].
After fusion of the viral glycoproteins with the host plasma membrane, the tegument
proteins and the capsid containing the DNA are released in to the cytosol. For efficient
replication of the viral DNA in the nucleus of the infected cell, the capsid has to be
transported from the plasma membrane across the cytosol to the nuclear membrane.
Diffusion cannot be utilized by the HSV-1 capsid across the cytoplasm as it has been
calculated that a HSV capsid would take over 200 years to travel just 1cm if diffusion
was the only mode of transport[11]. In case of neurons that have the cell body, dendrites
and an axon, where the dendrites are highly branched and elongated and an axon which
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can be as long as one meter, diffusion cannot be utilized as the optimal means of
transport .These cytosolic capsids are ably transported to the nucleus along the
microtubules [12]. HSV-1 an alphaherpesvirus undergoes replication in the epithelial
cells of the host at the site of infection before entering the nervous system. The viral
particles enter the peripheral nervous system where they are transported towards the cell
body in a retrograde manner to initiate latent infection in the sensory neurons of the
dorsal root and trigeminal ganglia. However, reactivation of the virus from latency causes
the viral particles to be transported to the periphery in an anterograde manner. In case of
neuronal cells as well, the capsids are transported along the axons to the neuronal cell
body, which utilizes the microtubule network. The capsids have been shown to move in
minus end direction towards the microtubular organizing centers (MTOC)[13].
Cytoplasmic dyneins are known to transport payloads towards the minus end of
microtubules (retrograde transport), which is usually the center of the cell, while kinesin
motors usually transport payloads towards the plus end of microtubules (anterograde
transport) which is the cell periphery [14-16]. The retrograde transport of the capsids has
been shown to be disrupted when the cells are pretreated with microtubule
depolymerizing agents such as nocodazole or colchicine suggesting that the microtubule
network is required for entry into the nucleus[13, 17].
These cargo transporters, are usually made up of multiple subunits with their molecular
weights ranging from 1.5 MD for dynein, 1.2 MD for dynactin, 340-380 kDa for kinesin1 and 260-280 kDa for kinesin-2 (Plus and minus end paper). Dynein belongs to the
AAA+ superfamily (ATPase associated with various cellular activities), and cytoplasmic
dynein is a large complex made of two heavy chains (DHCs), two intermediate chains
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(ICs), two light intermediate chains (LICs) and several light chains (LCs) [14, 18]. The
heavy chain consists of the cargo binding domain (N-terminus) and the motor domain (Cterminus) made up of six AAA ATPase domains in the form of a hexameric ring that
causes the movement by utilizing the energy released during ATP hydrolysis [19] and has
a stalk that binds to microtubule [20]. Alpha herpes viruses such as HSV-1, pseudorabies
virus (PrV) and the retrovirus human immunodeficiency virus type 1 (HIV-1) and
adenovirus, exploit cytoplasmic dynein of the host cell which along with its co-factor
dynactin, causes their directional movement towards the MTOC during their initial stages
of infection [21, 22]. Majority of the outer tegument proteins remain at the plasma
membrane along with the glycoproteins upon fusion of the virus at the cell membrane
causing the inner tegument proteins attached to the viral capsids to be exposed in the
cytoplasm [23, 24]. Experiments have shown that purified dynein motor can bind to
tegumented capsids and do not depend on the presence of any host proteins for this
binding. Lack of capsid proteins such as VP26, pUS11or VP11/12 did not seem to affect
the transport of these capsids to the nucleus and thus may less likely have the binding
sites for the dynein motors. These interactions are further supported by in vitro
experiments in which capsids complexed with inner tegument proteins were able to
associate with the microtubule motors, while the capsids lacking the tegument proteins
did not [25].Also, the failure of nuclear capsids to bind to the MAPs (microtubule
associated proteins) would suggest that the tegument proteins are more likely the
candidates for binding the motor proteins. Studies using recombinant viruses having
different tagged viral proteins for tracking showed that the major tegument proteins UL36
and UL37 can be detected in capsids undergoing retrograde transport in neuronal cells
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and this protein complex along with the capsid persisted together even after reaching the
nuclear membrane, while majority of the other tegument proteins are lost from the
capsids during this transport, similar to the findings in epithelial cells [21, 26, 27]. Thus
these inner tegument proteins UL36 and UL37 may be a few of other proteins that serve
as strong candidates that potentially recruit dynein motor [28, 29]. The HSV-1 UL37 is a
120kDa phosphorylated tegument protein expressed in both mature virions and light
particles [30]. UL37 protein is known to interact with proteins pUL46, pUL35 [31, 32]
and pUL36 and this interaction of pUL37 with pUL36 is known to be critical for
transport to the TGN [33, 34]. The pUL36 interacts with the outer tegument protein
pUL48 [32] and the minor capsid protein pUL25 [35, 36] In addition to envelopment,
which is associated with egress, pUL36 and pUL37 have also been implicated in
intracellular transport, as it has been shown in both HSV1 and PrV that lack of either one
of these proteins impairs the intracellular trafficking of viral capsids to the nucleus [37].
Here we show by proximity ligation assay (PLA), a sensitive method to detect proteinprotein interaction, that pUL37 potentially interacts with dynein motor protein during
entry. This interaction is visualized as bright red spots of fluorescence and the interaction
seems to be occur starting as early as 30 minutes post infection and seem to persist 2 hrs
post entry, while very minimal to no signal is detected after 16 hrs, indicating that may be
at 16 hpi the dynein motors may not be engaged with the viral capsids and the nuclear
capsids might be associated with kinesin motors which aid in the transport of the capsids
towards the plasma membrane of the cell.
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Materials and Methods
Cell Lines
African green monkey kidney (Vero) cells were obtained from the American Type
Culture Collection (Rockville, MD) and was maintained in Dulbecco’s modified Eagle’s
medium (Gibco-BRL; Grand Island, N.Y.), supplemented with 10% fetal calf serum and
antibiotics. CHO-nectin-1(human) cells were a gift from Richard Longnecker
(Northwestern University, Chicago, IL) and CHO-neo cells were a gift from Yasushi
Kawaguchi (The University of Tokyo, Japan). Both these cell lines were propagated in
Ham's F12 growth medium supplemented with 10% FBS and 200 μg/ml G418 and 250
μg/ml G418 respectively.
In situ proximity ligation assay analysis of protein interactions in virus infected
cells.
Vero cells were grown on 8 well chamber slides (Nunc Lab-Tek II chamber slide system)
and infected with F strain virus at an MOI of 10. At 18 hours post infection, the cells
were fixed with ice cold methanol for 10 minutes at -20°C. After three washes with PBS,
the samples were blocked for 2 hrs at 37°C with the Duolink blocking buffer in a
humidity chamber. Primary antibodies that were raised in two different species were
diluted in antibody diluting buffer and added to the samples and were incubated
overnight at 4°C. Mouse anti-dynein antibody against intermediate chain I (Abcam) and
rabbit anti-UL37 antibody (a gift from Dr. Frank J. Jenkins, University of Pittsburgh
Cancer Institute) were used for dynein/UL37 detection, respectively in Vero, CHO-neo
and CHO-nectin cells. Mouse anti-gD antibody and rabbit anti-nectin-1 antibody (Santa
Cruz) was used for positive control for gD/nectin-1 interaction in Vero cells. Mouse antidynein antibody and rabbit anti-gM antibody was used as negative control for dynein/gM
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interaction on Vero, CHO-neo and CHO-nectin-1 cells. Anti-microtubule antibody
(Abcam) was used for microtubule detection. Unbound primary antibodies were removed
by washing with 1X TBS-Tween20 (0.05%) three times, five minutes each. The Duolink
insitu PLA probes, Anti-Rabbit Plus and Anti-Mouse Minus, were added to the samples
(1:5 dilution) and incubated at 37°C for 1hr. After the incubation step, washes were done
with Duolink wash buffer A, twice for five minutes each. The ligation stock was diluted
1:5 in high purity water and added to the wells (40 to 80ul) and the slides were incubated
at 37°C for 30 minutes. The slides were washed with buffer A three times, five minutes
each and amplification solution (40 to 50ul) was added and were incubated for 1.5 hrs at
37°C. The slides were then washed with wash buffer B twice for 10 minutes each and
washed once with 0.01% of buffer B. The slides were then mounted with mounting media
(Duolink II) and the slides were stored at -20°C and protected from light until confocal
images were taken. The confocal images were taken using a 60X objective on an
Olympus FluoView FV10i confocal laser scanning microscope.
The virus was allowed to attach to confluent monolayer of vero cells at 4°C for 1hour and
shifted to 37°C to allow virus entry and the chamber slides were removed at various time
points 0, 30, 2 hrs, 3 hrs, 6 hrs, 9 hrs, and 12 hrs and fixed with ice-cold methanol and
proceeded with proximity ligation assay.
In situ proximity ligation assay analysis of protein interactions in virus infected
dorsal root ganglia
Dorsal Root Ganglia were dissected from fetal Sprague-Dawley rats at embryonic days 8
to 10 and seeded on Poly-D-Lysine 8-well Culture Slides (Catalog number: 354632 BD).
Similarly aged Rat DRG was also obtained commercially (Catalog number: DRG –
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BrainBits). Maintenance tissue culture medium consisted of neural basal medium with B27 supplement, at the manufacturer’s recommended concentration (Invitrogen, Grand
Island, NY). Medium was supplemented with 50 ng/ml neural growth factor 2.5s
(Invitrogen), 2%normal rat serum (Invitrogen), 1_GlutaMAX (Invitrogen), and 0.2%
Primocin (InvivoGen, San Diego, CA). The ganglia were monitored regularly for axonal
growth and supplemented with neuro-basal media supplemented with neuronal growth
factors. A healthy extension of axons was observed 7 days post seeding and the ganglia
were ready to be infected. The media was then removed and 200,000 PFU of either wildtype McKrae or mutant gKΔ31-68 virus was added to the ganglia. The virus was
removed after 1 hour incubation time at 37C and the slides were fixed with ice cold
methanol for 10 minutes at -200C. PLA assay was performed on these slides as described
earlier.
Results
The inner tegument protein UL37 interacts with the motor protein dynein during
transport of the viral capsids to the nucleus
Proximity ligation assay shows the interaction of the tegument protein UL37 with the
motor protein dynein. This interaction is visualized as bright red spots of fluorescence
which can be seen starting from 30 minutes post entry. After the initial attachment of the
virus to the cell, glycoprotein D is known to interact with one or more of its specific
receptors causing virion attachment and entry. We utilized nectin-1 which is one of its
specific receptors for our positive control. Bright red fluorescent signals were visualized
which shows the interaction of gD with nectin-1 at zero time point. The gM /dynein
combination was used as negative control for both zero and 16 hrs time points, because
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after the fusion of viral glycoproteins with the host cell membrane only the tegument
proteins and the capsid containing DNA are released in to the cytosol of the host cell.
Consequently, gM dynein interaction is physically improbable. As expected, no red
fluorescence signals were seen indicating the absence of gM-dynein interaction.
For the pUL37-dynein interaction, the virus was allowed to attach to the cells for 1 hr at
4°C followed by incubation times 0 min, 30 min, 2 hrs, 6 hrs, 9 hrs, 12 hrs, 14 hrs and 16
hrs at 37°C to allow virus entry. The signals were seen at all-time points except for 0
minutes. Visually, the signals seemed to be a maximum at 30 minutes with some seen at
2 and 6 hrs. At 9 hrs post entry, the signals seemed to have a pattern where they
accumulated around the nucleus. Although, at 12, 14 and 16 hrs post entry the signals
seemed to dissipate and were minimal (Fig 2 A & B).
We have shown previously that the gK 31-68 virus (the first 68 aa deleted which includes
the first 30aa signal sequence) enters very slowly in the Vero cells when compared to the
wild type virus. Here we saw only a few signals for the pUL37-Dynein interaction for the
gK 31-68 virus showing the slow entry of the virus into the cells compared to the wild
type, however the signals for gD-nectin-1 interaction in both the viruses appeared to be
similar.
Dorsal root ganglia resected from 8-10 day old Sprague-Dawley rat embryos were seeded
on PLL coated 8 well chambered slides and cultured in neuro basal medium
supplemented with neuronal growth factors. The Ganglia exhibited robust growth of
axons 7 days post seeding and were used for infection studies. As with Vero cells gM-

98

Dynein interaction was used negative control. Red fluorescent signals representing gDNectin interaction were observed on the axonal surface in the case of both wild type

Figure 4.2. Proximity ligation assay of UL37- dynein interaction on Vero cells. Confluent
Vero cells were grown on 8 well chamber slides. HSV-1 F strain virus at an MOI of 10
was used to infect the Vero cells and the slides were rocked at 4°C for one hour for the
binding of virus to the cells and shifted to 37°C to aloe entry. The cells were fixed with
ice-cold methanol for 10 minutes at -20°C followed by proximity ligation reaction as
described in the materials and methods. gM/dynein antibody pair was used as a negative
control and it was used for 30 min and 16 hrs time point while gD/nectin-1 antibody pair
was used as positive control at zero time point (A), The remaining time points utilized
pUL37/dynein antibody pair to determine the interaction of these two proteins at different
time points post entry. The virus was allowed to enter at varying time points, 0, 30 min, 2
hrs, 6 hrs, 9 hrs, 12 hrs, 14 hrs and 16 hrs (B)
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Figure 4.3. Comparison of UL37/dynein interaction in WT and gK 31-68 viruses.
Confluent Vero cells grown on 8 well chamber slides were infected with HSV-1 F strain
virus at an MOI of 10. The slides were rocked at 4C for binding of virus to the cells for
one hour and shifted to 34C to allow entry. At one hour post infection, the virus was
removed and cells were fixed and PLA assay was performed as described in materials
and methods. Interaction between gD and nectin-1 was studied in both these viruses as
control (A). UL37/dynein antibody pair was used to study the interaction between these
proteins in the cells (B).
Dorsal root ganglia resected from 8-10 day old Sprague-Dawley rat embryos were seeded
on PLL coated 8 well chambered slides and cultured in neuro basal medium
supplemented with neuronal growth factors. The Ganglia exhibited robust growth of
axons 7 days post seeding and were used for infection studies. As with Vero cells gMDynein interaction was used negative control. Red fluorescent signals representing gDNectin interaction were observed on the axonal surface in the case of both wild type
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McKrae as well as gK31-68 infections. In DRG axons infected with wild type virus the
pUL37-Dynein probe combination yielded Red signals indicating the entry of the virus
and interaction of UL37 with dynein. However no such signal was observed in DRG
axons infected with gKΔ31-68 which suggest that the virus was stuck on the surface. As
with Veros the gM-Dynein combination did not yield any signals (Fig 4 A, B, C, & D).
Discussion
Many new techniques and methods come in to existence in the field of proteomics that
help us to understand and acquire insights in protein structure, functions, modifications
and interactions and so on.
PLA is a relatively simple tool to detect protein-protein interactions. This technique has
also been utilized for detecting infectious agents and proteins with a sensitivity rated
higher than much established technique like PCR [38]. Here we have used the technique
to understand the entry and transport of HSV-1 towards nucleus. This technique can be
utilized to detect the entry of virus to the cytosol of infected cells even if the virus fails to
enter nucleus and start protein synthesis Thus is helpful in differentiating between virus
stuck at the cell plasma membrane or inside the cell giving more insight into which steps
of viral life-cycle are affected. The HSV-1 proteins shown to be interacting with dynein
are nuclear protein UL34 through GST pulldown experiment and capsid protein VP5 and
helicase UL9 using Pepscan [39]. Through biochemical analysis and live imaging suggest
VP1/2 (UL36) and UL37 are the two most suspected candidates for interacting with
dynein [37]. We are able to report the proximity between cellular motor protein dynein
and the herpes viral tegument protein UL37. Our data suggested close physical
interaction between dynein and UL37 throughout replication cycle. Studies showing
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interactions between viral proteins and cellular motors are very limited and part of the
reason may be because dyneins are tremendously large multimeric proteins with
molecular mass ranging from 1,000K-2,000K [40]. In this scenario, PLA can be used to
unfold the mysteries of protein-protein interactions rather than opting for the difficult
techniques of immunoprecipitation and western blots. It is shown that at zero min there is
no interaction between the two proteins as the virus has not even entered the cells and the
interaction shows up at later time points. Negative control experiments using membrane
protein gM and dynein did not show any interaction at both early and late time points.
This clearly supports the belief that it is not the membrane proteins, but the outer capsid
or inner tegument proteins are involved in cellular transport of virus. The interaction
between pUL37 and dynein starts from the time of viral entry to cells, then intensifies and
cluster around nine hours and finally disseminate and vanishes towards later time point.
Clustering of interaction during egress suggest that dynein may have a passive role
during exit by being part of the motor system and also more pUL37 is present as new
viruses are being made Further works need to be done to dissect where the interactions
between dynein and UL37 is happening.
Our lab has shown that the gK mutant virus, gKΔ31-68 lacking 68 aa from its amino
terminus (including the 30-aa signal sequence) entered vero cells less efficiently
compared to wild-type virus [3]. Through PLA we have supported the observation by
showing fewer signals for pUL37-Dynein interaction for gKΔ31-68 when compared to
wild-type virus though the interaction between gD-nectin remained similar for both the
viruses showing that the attachment between virus and cell was not affected by the
mutation on gK . A critical aspect of the life cycle of HSV-1 is the entry into axons and
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establishment of latency in the ganglia. With the development of HSV-1 as a highly
potent oncolytic vector/vaccine, it is of critical importance to develop recombinant HSV1 strains capable of delivering oncolytic payloads, without infecting axons and
establishing latency in the ganglia. We believe that 31-68 aa region of the aminoterminal region of HSV-1 glycoprotein K plays a critical role in modulating gB mediated
entry into axons. In order to prove this hypothesis we have seeded dorsal root ganglia
resected from 8-10 Sprague-Dawley rat embryos to seed them on poly-L Lysine coated *
well chambered slides. In presence of Neuronal growth factors, a robust growth of axonal
fibers extending away from the neuronal bodies within the ganglionic cluster was
observed. Infection of these axonal regions with both wild type McKrae and gKΔ31-68
virus followed by the proximity ligation assay similar to the vero studies described earlier
reinforced our hypothesis. In the case of the wild type infections, red fluorescent signals
were observed for both gD/Nectin as well pUL37-Dynein combination. However in the
case of gKΔ31-68 red fluorescent signals were observed only for the gD/Nectin
interaction. The absence of pUL37-Dynein interaction in gKΔ31-68 infections suggest
that i) either the virus is unable to enter the axons and is stuck on the surface or ii)
gKΔ31-68 is altering the configuration of UL37 rendering it incapable of interacting with
Dynein axons. The latter is a highly unlikely scenario with no empirical evidence to
support it and also as virus loses its membrane proteins and many tegument proteins
subsequent to the entry into cell after fusion This interaction study demonstrates one of
the practical applications of PLA. Thus PLA can be used as a very convenient and useful
tool in exploring the life-cycle events of the virus.
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CHAPTER V
CONCLUDING REMARKS

Summary
The Herpes Simplex virus has a very complex life cycle and in which envelopment and
egress are important events. Viral membrane proteins and tegument proteins functions
together in order to get the virus successfully envelop and egress out of the cell. The
important membrane proteins required for the step are glycoproteins gM, gK, gE and
non-glycosylated membrane proteins UL20 and UL11. Among all the most important is
the UL20/gK complex [1]. UL20p is a structural protein made of 222 amino-acids which
is non-glycosylated and has transmembrane domains. It is highly conserved among
alphaherpesviruses like varicella-zoster [2], pseudorabies virus (PRV) [3] and the
gammaherpesvirus Marek’s disease virus type 2 [4]. Works done in my laboratories have
show that UL20p deletion resulted in accumulation of unenveloped capsids in the
cytoplasm of infected cells [5] . Mutant viruses were made with mutations in the carboxyl
termini of UL20p especially targeting Phenylalanine residues which may be an important
target for protein-protein interactions through stacking of the aromatic structure. The
mutation of approximately middle phenylalanine to alanines has an advantageous effect
on the virus as evidence by an increased titer at end the replication study and also a lower
particle to PFU ratio reflecting the higher efficiency of viral envelopment. Another
important observation of the study was the importance of the double phenylalanine
residue proximal to the membrane. Replacement of those phenylalanines to alanines
affected the replication capabilities of the virus and also the envelopment efficiencies.
The protein structure predicted by SOSUI programme showed that the carboxyl terminal
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is retracted from the intracellular space and this might have affected the ability of the
protein to interact with tegument proteins during envelopment.
In the second study, we have showed that the deletion of amino terminus of viral envelop
protein gK has affected the entry of HSV-1 into Vero cells and neurons through PLA
technique. gK like UL20p has multiple transmembrane regions and is made of 338 amino
acids encoded by the UL53 open reading frame . PLA is a sensitive method to detect
protein-protein interaction [6]. After entry to cell, virus recruits cellular motor proteins
for their transport to the nucleus and for the retrograde transport dynein is the motor
protein of interest. The most suspected tegument protein interacting with dynein is the
inner tegument protein of virus UL37. PLA technique has been standardized to show the
interaction between UL37 protein and dynein. Here the technique has been successfully
shown the entry and transport of HSV-1 towards the nucleus and can be used as a method
to evaluate viral entry to the cytoplasm of infected cell. Using the technique it has been
shown that the gKΔ31-68 lacking 68 aa from its amino terminus entered slowly into vero
cells and in case of neurons there is complete absence of signals indicating the inability
of the virus to enter neurons. It is interesting to note that the viral attachment to cell
surface is not affected in either case suggesting the later step after entry is affected and
deletion of amino terminus of gK is not hindering the attachment step.
Future Studies
In chapter II, phenylalanine residues at the carboxyl terminus of UL20p has been shown
have regulator effect on infectious virus production and envelopment. Additional work
need to be done to further understand the how the deletion or replacement is affecting
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envelopment and egress of the mutant viruses. Peptides of UL20 carboxyl terminus can
be used to study whether they are able to complement the behavior of mutant viruses.
Plans are there to use the viruses in an invitro neuronal system to study the anterograde
and retrograde transport and to have a better understanding about the behavior of virus in
neurons. Furthermore, mice can be infected with the viruses to study pathogenesis of
infection.
In chapter III, PLA was used to support and explore the role of amino terminus of gK in
entry to Vero cells and neurons respectively. This technique is a valuable tool to detect
the entry of virus to cells. It can be used to study similar entry defects in different
membrane proteins mutant viruses and used to explore which all domains are critical for
entry. Apart from entry, egress can also be studied by using the different motor protein
kinesins, which are important for anterograde transport. Thus PLA can be used as a very
convenient and useful tool in exploring the life-cycle events of the virus.
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